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1. Introduction 
 
Undoubtedly one of the most intriguing features in multicellular organisms is how the 
myriads of cells in the body “talk” to each other. The clear advantage of multicellular over 
single-cell life forms is that by collaboration and division of labour it became possible to 
exploit resources that no single cell could utilise so well (Alberts B, et al., 1994). One well 
known example of a simple multicellular organism is the green algae volvox, comprised of 
about 50.000 cells forming a hollow sphere. Within the volvox colony there is division of 
labour among cells, with a small number being specialised for reproduction and serving as 
the precursors for the next generation. The other cells are dependent on one another and 
the organism dies if the colony is disrupted. Even in this relatively simple and small life form 
there arose the need for cells to communicate with each other, setting up signals to govern 
the character of each cell according to its place in the structure as a whole. How much 
greater is the necessity in highly complex multicellular organisms, such as vertebrates where 
more than 200 distinct cell types can be distinguished and many more subtler varieties 
(Alberts B, et al., 1994). 
An animal cell contains an elaborate system of proteins that enables it to respond to signals 
from other cells. Signals can be transmitted over vast distances in the body in the form of 
hormones through the blood stream. Another way to cover distances is by extreme 
morphological adaptation of cells such as neurons, whose processes can contact target cells 
far away. Signalling molecules can be very diverse and include proteins, small peptides, 
steroids, retinoids, fatty acid derivates or dissolved gases, such as nitric oxide (Alberts B, et 
al., 1994). Signals can furthermore be soluble, bound to the extracellular matrix or 
presented on the surface of neighbouring cells and act in millions of combinations. The way 
a cell responds to these depends on the combination of signal receptors it possesses and its 
intracellular machinery through which it integrates and interprets the signals it receives. How 
it comes about developmentally that subsets of cells express different combinations of 
receptors and intracellular signalling molecules is itself regulated through intercellular 
communication. The general principle is that cells respond through receptors on their surface 
to extracellular signals and pass this information on to the inside of the cell where in turn it 
is propagated by a cascade of intracellular proteins that eventually determine the cell’s 
response. Cells can respond to signals quickly for example by rearranging their 
cytoskeleton thus affecting morphology or migratory behaviour, or more slowly by 
influencing gene expression and thereby changing the molecular composition and 
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consequently the responsive properties of the cell. With the exception of intracellular 
receptors that bind to hydrophobic molecules diffusing into the cell, receptors are most 
often cell surface proteins with high affinity for their specific signal or ligand (Alberts B, et 
al., 1994). There are three known classes of cell-surface receptors each activating 
intracellular events through different mechanisms (Alberts B, et al., 1994). Ion-channel-linked 
receptors or transmitter-gated ion channels, e.g. glutamate-gated cation channels such as 
the NMDA-receptor are regulated in their open-or-closed state through binding to their 
ligand and thereby influence the ion permeability of the plasma membrane and thus the 
excitability of the neuron. G-protein-coupled receptors (GPCRs) are seven-transmembrane 
domain proteins that act indirectly through a trimeric G-protein to influence a separate 
protein such as an ion channel or an enzyme. Finally the third class are the enzyme-linked 
receptors, mostly single-pass transmembrane proteins, the majority of which are protein 
kinases that phosphorylate intracellular signal transducers. The best known class are the 
Receptor-Tyrosine-Kinases (RTKs), with such prominent members as Epidermal-Growth-
Factor Receptor (EGFR) or the Eph receptors. The Eph receptors and their ligands, the 
ephrins, shall be of particular interest to this study and will be further introduced in the next 
chapter. 
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1.1 Eph receptors and ephrin ligands 
 
Eph receptors and their ligands, the ephrins, are found throughout the animal kingdom but 
are most numerous in vertebrates. There, they have been reported to be involved in a vast 
array of biological functions ranging from vascular development, tissue-border formation 
and cell migration to axon guidance and synaptic plasticity (reviewed in  (Klein, 2004; 
Palmer and Klein, 2003; Poliakov et al., 2004; Wilkinson, 2001). In contrast to vertebrates, 
only one Eph receptor and 4 ephrins are found in Caenorhabditis elegans (George et al., 
1998; Wang et al., 1999) and Drosophila has only a single Eph and a single ephrin, which 
are expressed within the embryonic CNS at a time when neurons are extending axons 
towards their targets (Bossing and Brand, 2002; Scully et al., 1999). It has recently been 
shown that they too act as a functional receptor-ligand pair in vivo since Eph receptor null 
mutant flies show an axon guidance phenotype in a subpopulation of mushroom body 
neurons (Boyle et al., 2006). 
The Ephs and ephrins differ from most described receptor-ligand pairs in that both the 
receptor as well as the ligand are membrane residents. Thus signalling is only elicited upon 
cell-cell contact unlike in systems with diffusible ligands. Another unique feature of this 
particular system is that also the ligand can induce intracellular signalling, termed “reverse” 
signalling (Bruckner et al., 1997; Holland et al., 1996) in contrast to “forward” signalling 
taking place in the receptor cell. This bi-directional signalling can mediate attraction 
between the cells in contact as has been described for the establishment of the vomeronasal 
projection in the mouse. Here vomeronasal axons expressing high levels of ephrinA5 project 
onto regions of the accessory olfactory bulb with high EphA6 receptor concentration (Knoll 
et al., 2001). Repulsion on the other hand is the more prominent outcome of Eph-ephrin 
signalling as is well exemplified by the guidance of EphA4-positive corticospinal tract (CST) 
axons repelled by ephrinB3-positive spinal cord midline cells (Kullander et al., 2001a; 
Kullander et al., 2001b). 
To complicate the picture of Eph and ephrin signalling even further, it has become clear that 
there are many cell types in which receptor and ligand are co-expressed contrasting the 
classical complementarity of Eph and ephrin expression domains (Hornberger et al., 1999; 
Iwamasa et al., 1999). Marquardt and colleagues recently showed that co-expressed EphA 
and ephrinA in spinal motor neurons segregate to distinct membrane domains and can be 
activated by their respective binding partner presented by opposing cells (in trans). Within 
the same growth cone ephrinA and EphA mediate opposite functions, either growth or 
collapse, respectively. This differential localisation is essential since a forced co-localisation 
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of receptor and ligand leads to a disruption of correct signalling outcome (Marquardt et 
al., 2005). 
Recent studies have shown that in addition to bi-directional signalling, there is also bi-
directional endocytosis of Ephs and ephrins, sometimes termed “trans-endocytosis” (Marston 
et al., 2003; Zimmer et al., 2003), a phenomenon that will be discussed in detail in chapter 
1.3.3). 
 
 
The Eph receptors 
 
Amongst the family of Receptor Tyrosine Kinases (RTKs), the Eph receptors constitute the 
most numerous subfamily. Based on sequence similarity and ligand binding preferences they 
are grouped into ten EphA class receptors that bind to ephrinA ligands and six EphB class 
receptors that bind to ephrinB ligands. Within the A- and B- classes there is a certain 
degree of promiscuity, e.g. one EphA receptor is usually able to bind to several ephrinA 
ligands although with different affinities. A-class receptors generally have no affinity for B-
class ligands with the exception of EphA4 that can in addition to A-class ligands also bind 
to ephrinB2 and ephrinB3 (Pasquale, 2004). The interaction is initiated by one receptor 
molecule and one ligand molecule coming into contact via the receptor’s globular domain 
and a conserved Eph-binding domain in the ephrin (Lackmann et al., 1997). 
Crystallography has provided structural details of the receptor ligand interaction showing a 
high affinity ephrin-binding site within the extracellular part of the Eph receptor that 
mediates hetero-dimerisation accompanied by a lower affinity site mediating 
tetramerisation (Himanen and Nikolov, 2003a; Himanen and Nikolov, 2003b). Eph 
receptors have an evolutionary highly conserved domain structure (Drescher, 2002), with 
the aforementioned globular domain in the extracellular part which is necessary and 
sufficient for ligand binding (Labrador et al., 1997; Lackmann et al., 1998), followed by a 
cysteine-rich linker, an EGF-like motif, and two type III fibronectin domains (Figure 1). A 
single transmembrane region connects to the cytoplasmic part comprising of a 
juxtamembrane segment with 2 conserved tyrosine residues, a protein tyrosine kinase 
domain, a sterile-α-motif (SAM) and a PDZ (PSD-95, Disc large, ZO [Zona Occludens]-1/2) 
-binding motif (Kullander and Klein, 2002). 
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Figure 1 Schematic representation of the Eph receptor structure 
The Eph receptor structure shown in its inactive conformation on the left side where the kinase 
activity is auto-inhibited by interaction with the juxtamembrane (JM) region. On the right side 
the Eph receptor structure in its active conformation. 2:2 hetero-tetramerisation with ephrin 
ligands (not depicted) leads to phosphorylation of the two JM tyrosines and thus relieves the 
auto-inhibition. Phosphate groups in light green. SAM (sterile-α-motif), a protein-protein 
interaction domain, PDZ (PSD-95, Disc large, ZO [Zona Occludens]-1/2) binding motif, a 
short stretch of amino acid recognized by PDZ domain containing proteins in a sequence 
specific manner. Scheme adapted from (Himanen and Nikolov, 2003b) 
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The ephrins 
 
In vertebrates there are five ephrinA and 3 ephrinB ligands. A-class ephrins are tethered to 
the membrane by a glycosylphosphatidylinositol (GPI) anchor, while B-class ephrins are 
transmembrane proteins that contain a cytoplasmic tail with five highly conserved tyrosine 
residues and a conserved C-terminal PDZ-binding motif (Figure 2) with a consensus 
sequence of –YKV (Bergemann et al., 1998). As already described for the Eph receptors, 
intra-class binding is promiscuous but inter-class binding is the exception with ephrinB2 and 
–B3 being ligands for EphA4 and ephrinA5 which has recently been reported to bind to 
EphB2 (Himanen et al., 2004). The ephrins do not have any intrinsic catalytic activity but 
ephrinB ligands can be phosphorylated upon stimulation with EphB receptor (Bruckner et al., 
1997; Holland et al., 1996). This can be mediated by src-family kinases (SFK) which are 
recruited to ephrinB clusters (Palmer et al., 2002).  
 
 
Figure 2 Schematic representation of Ephrin ligand structure  
Ephrins are either tethered to the membrane by a GPI anchor (ephrinA1-A5) or have a single 
membrane-spanning domain (ephrinB1-B3). Both classes bind to Eph receptors via their 
conserved Eph-binding extra-cellular domains. B class ephrins have a cytoplasmic tail 
containing five conserved tyrosines that can be phosphorylated (shown as green circles) and a 
C-terminal PDZ binding motif which provides a docking site for PDZ domain containing 
adapters. TM (transmembrane domain). 
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1.1.1 Eph and ephrin signalling 
 
In other receptor-ligand systems, it has been shown that RTK monomers usually dimerise 
upon binding to their diffusible ligands which leads to trans-autophosphorylation of the 
receptor monomers and initiation of an intracellular signalling cascade (Schlessinger, 2000). 
In the case of Eph-ephrin mediated events though, dimerization is not sufficient to elicit 
physiological signalling. After the initial hetero-di- and hetero-tetramerization, Eph and 
ephrins form higher-order oligomers and can eventually aggregate into large clusters the 
size of which might depend on the expression levels of receptor and ligand (Smith et al., 
2004). It has been reported by Yancopoulos and colleagues that either membrane 
attachment or artificial clustering of ephrin ligands is needed to activate Eph receptors 
(Davis et al., 1994) and vice versa that also receptors need to be pre-clustered in order to 
achieve ephrinB phosphorylation (Bruckner et al., 1997; Holland et al., 1996). There are 
low-affinity interactions amongst the ephrins, namely between their extracellular domains 
and possibly their juxtamembrane cytoplasmic segments, as well as among the Ephs which 
display homophilic binding with their ephrin-binding domains, cysteine-rich regions and 
cytoplasmic SAM domains (Himanen and Nikolov, 2003b). In addition to these interactions, 
PDZ domain containing adapters bound to the cytoplasmic tail of the Eph receptor and/or 
the ephrinB ligand might help to stabilize the clusters. On the receptor side it has recently 
been reported that Eph clusters exceed the size of the interacting ephrin surface several 
fold and that cluster expansion on the membrane of the Eph-expressing cell is independent 
of ephrin but instead mediated by direct Eph-Eph interactions (Wimmer-Kleikamp et al., 
2004).  
 
 
Forward signalling by Eph receptors 
 
Since signalling by Eph receptors is involved in many different developmental and 
postnatal processes as well as many different tissues and cell types, this short introduction is 
by no means trying to give a comprehensive overview. Instead it focuses on general 
features in the molecular events downstream Eph receptors and some prominent examples 
of forward signalling in the nervous system. There is a plethora of intracellular signal 
transducers that have been associated with Eph receptors, some of them identified only 
through in vitro studies and few of them shown to have biological relevance (Kullander and 
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Klein, 2002; Pasquale, 2005). For an overview of the Eph receptor interacting molecules 
see Figure 3. 
 
 
Figure 3 Eph receptor interacting molecules 
Proteins so far identified to interact with EphA receptors are depicted in blue, those up to now 
specific to EphB receptors in red, common interactors for both are shown in purple. Phospho-
tyrosines are represented by light green circles, activation of a pathway as arrows, repression 
by a bar. For simplicity, the interaction (of EphB2) with Syndecan-2 (a cell-surface heparan 
sulfate proteoglycan) in cultured hippocampal neurons which seems to be involved in positive 
regulation of spine formation via Intersection/Rac1 and Syntenin/Kalirin (Ethell et al., 2001; 
Irie and Yamaguchi, 2002; Penzes et al., 2003) is not depicted here. 
Abl/Arg (Abelson, Abl-related gene, cytoplasmic tyrosine kinases), AF-6 (afadin-6, tight 
junction protein and Ras effector), Cbl (Casitas B-lineage lymphoma, an E3 ubiquitin ligase), 
cdc42 (cell division cycle 42, a Rho-GTPase), Crk (Chicken retroviral kinase, a SH2/SH3 
adaptor), Ephexin (Eph-interacting exchange protein, a Rho GEF), ERK (extracellular-signal 
regulated kinase, a cytoplasmic and nuclear Serine/ Threonine kinase), GAP (GTPase 
activating protein), GEF (guanine nucleotide exchange factor), Grb (growth-factor receptor-
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bound, an SH2/SH3 adaptor), GRIP (glutamate-receptor-interacting protein, a seven PDZ 
domain scaffolding molecule), LMW-PTP (low-molecular-weight protein tyrosine phosphatase), 
MAPK (mitogen-activated protein kinase), Nck (non-catalytic region of tyrosine kinase 
adaptor protein 1, an SH2/SH3 adaptor), PI3K (Phosphatidylinositol3-kinase), PICK (protein 
interacting with C kinase, PDZ domain containing adaptor), Rac1 (Ras-related C3 botulinum 
toxin substrate 1, a Rho GTPase), RhoA (Ras homologue A, a cytoplasmic GTPase, a Rho 
GTPase), SFK (src-family kinases, cytoplasmic tyrosine kinases), SH2 (src-homology2), SHEP1 
(SH2-domain-containing Eph receptor-binding protein 1, a Ras GEF), SLAP (src-like adaptor 
protein), Vav (Vav oncogene, exchange factor for Rho-family GTPases), scheme adapted 
from (Kullander and Klein, 2002; Pasquale, 2005) 
 
Ligand stimulation by ephrins leads to autophosphorylation of the two juxtamembrane (JM) 
tyrosines in the Eph receptor which is critical for activation of the protein tyrosine kinase 
domain (Binns et al., 2000; Kullander et al., 2001a; Zisch et al., 2000). As depicted in 
Figure 1, phosphorylation of the JM tyrosines relieves the auto inhibitory interaction 
between the JM and the kinase domain. Furthermore, Eph receptors can be phosphorylated 
on tyrosine by src-family kinases (SFKs) which can also directly bind to the JM tyrosines via 
their SH2 domains (Ellis et al., 1996; Zisch et al., 1998). Several studies have been 
performed mutating the two conserved JM tyrosines to address their biological relevance in 
vitro and in vivo. Kullander and colleagues replaced the JM tyrosines in EphA4 with 
phenylalanines (EphA42F/2F) (Kullander et al., 2001b), resulting in a kinase-deficient 
receptor, whereas Egea and co-workers changed them to glutamic acids (EphA42E/2E) 
resulting in an open-conformation, hyper-active kinase mutant whose basal kinase activity is 
comparable or even higher than in ligand-activated wt receptor (Egea et al., 2005). In 
primary cortical cultures derived from EphA42F/2F homozygous mutant mice, no receptor 
autophosphorylation can be detected in response to ephrinB3 stimulation and although 
trans-phosphorylation mediated by EphA42F/2F can still occur, it is reduced. The signalling 
capabilities are further compromised in EphA42F/2F mutants due to the disruption of the SH2 
adaptor binding site, since EphA42F/2F failed to co-precipitate with SH2 domains of known 
interactors like Src tyrosine kinase or Grb10. 
 Since both EphA4 kinase dead (EphA4KD/KD) mutants as well as EphA42F/2F but not 
EphA42E/2E mice display aberrant recrossing of CST fibres at lumbar levels it could be 
concluded that CST axon guidance depends on a functional but not necessarily a ligand-
regulated kinase domain (Egea et al., 2005). Interestingly though, EphA42E/2E mutants 
displayed the same defects in thalamocortical projections (of dorsal thalamic axons to the 
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somatosensory cortex) that had previously been described for EphA4 null mutants (EphA4-/-
). Similar results can be observed for an EphA4 mutant where the cytoplasmic part has been 
replaced by GFP (EphA4GFP/GFP) constituting a “forward signalling” deficient mutant (Dufour 
et al., 2003; Egea et al., 2005). This elegantly showed that in some axon path-finding 
situations during development a fine tuning of kinase activity is required to sense a gradient 
of ephrin (ephrinA5) ligand for correct (thalamocortical) projections since the constitutive 
active EphA42E/2E did not rescue the kinase dead phenotype. An additional possibility that 
cannot completely be ruled out is that SH2 domain containing interactors of EphA4 are 
needed which can no longer bind to the Y to F or the Y to E mutants. On the other hand 
though, correct axon guidance of the CST is affected in kinase dead mutants but rescued in 
constitutively active mutants, arguing that interpretation of the repulsive cue provided by 
ephrinB3 at the midline is an all-or-nothing decision (Egea et al., 2005). 
In addition to the role that Ephs and ephrins play in guidance of thalamocortical and 
corticospinal axons, they have been shown to be instructive in the projection of retinal axons 
to the tectum in chick and the superior colliculus in mammals (for a comprehensive review, 
see (Lemke and Reber, 2005)). There are gradients of Eph receptors in the retina and 
ephrins in the tectum that set up the map. EphA3 expression is low in nasal and high in 
temporal neurons and the corresponding ephrins are ephrin A2 and-A5 whose levels are 
low in the anterior and high in the posterior tectum. This results in nasal to posterior and 
temporal to anterior projections due to the repulsive action of the receptors and ligands 
involved (Cheng et al., 1995; Drescher et al., 1997). This rather simple scheme has become 
more complex since recent evidence points to a cis-interaction between EphA3 on retinal 
axons with co-expressed ephrinA5 which might serve as a way of desensitising the axons 
towards ephrins presented in trans (Carvalho et al., 2006). Dorso-ventral mapping is 
achieved through high levels of EphB2 and-B3 in the ventral retina axons that project to the 
dorsal tectum, high in ephrinB1 and exemplifying an attractive/growth promoting action 
rather than repulsion (Braisted et al., 1997; Hindges et al., 2002; Holash and Pasquale, 
1995; Mann et al., 2002) although newer evidence also points to an involvement of 
ephrinB1 as a repulsive cue (McLaughlin et al., 2003). 
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Reverse signalling by ephrins 
 
Since the first evidence for “reverse” signalling was found 10 years ago (Bruckner et al., 
1997; Holland et al., 1996), an increasing number of studies have concentrated on 
elucidating the molecular events downstream of ephrins. Combining genetic tools such as 
knock-ins of signalling incapable receptors or ligands with cell-biological assays has clearly 
demonstrated the biological relevance of ephrin reverse signalling. Studies about reverse 
signalling include the role of ephrinBs in dorsal retinal axon pathfinding (Birgbauer et al., 
2000), requirement of ephrinB2 cytoplasmic domain in proper vascular development 
(Adams et al., 2001), a cell-autonomous role of ephrinB1 reverse signalling for neural crest 
cell migration (Davy et al., 2004), requirement of ephrinB reverse signalling for NMDA-
independent mossy fiber LTP (Armstrong et al., 2006), and many others (Cowan et al., 
2004; Dravis et al., 2004). For a comprehensive overview of reverse signalling, there are 
several excellent reviews available (Davy and Soriano, 2005; Gauthier and Robbins, 
2003; Murai and Pasquale, 2003; Palmer and Klein, 2003).  
Although GPI-linked ephrinAs do not contain a cytoplasmic domain, it has been shown in 
cultured cells that their activation by Eph receptors results in an integrin-dependent 
adhesion to laminin (Huai and Drescher, 2001) and may involve intracellular kinases such as 
MAPK and Fyn (Davy et al., 1999; Davy and Robbins, 2000). Furthermore, ephrinAs seem 
to mediate at least some of the repulsive signalling on the anterior-posterior axis of retino-
tectal mapping (Knoll and Drescher, 2002) as well as acting as guidance “receptors” for 
EphAs on incoming sensory axons in the olfactory system (Cutforth et al., 2003). Frisén and 
colleagues used mice lacking ephrinA2 to show that EphA7 induces ephrinA2 reverse 
signaling, which negatively regulates neural progenitor cell proliferation (Holmberg et al., 
2005). EphrinA proteins presumably transduce signals by sequestration in raft microdomains 
and association with transmembrane proteins capable of activating intracellular signalling 
pathways, although the nature of these postulated ephrinA co-receptors remains to be 
discovered. Attenuation of ephrinA mediated reverse signalling has been proposed to 
involve cleavage by the Kuzbanian metalloprotease (Hattori et al., 2000). 
 
EphrinBs, on the other hand, do contain a cytoplasmic domain and considerable effort has 
been spent to uncover the active roles of the transmembrane ephrins during development 
and in adult model organisms. The B-class ephrins display a sequence identity of 95% in the 
last 33 amino acids of their conserved cytoplasmic tail, including five conserved tyrosines, a 
poly-proline stretch and a C-terminal PDZ binding motif (Figure 2). Among the growing 
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number of reverse signal transducers, Grb4 has been demonstrated to bind to ephrinB1 in 
a tyrosine phosphorylation dependent manner via its SH2 domain (Cowan and 
Henkemeyer, 2001). Furthermore, a group of PDZ domain containing proteins have been 
shown to interact with ephrinBs, including GRIP (Bruckner et al., 1999), PTP-BL (Palmer et 
al., 2002), PDZ-RGS3 (Lu et al., 2001), and it has been hypothesized that some of these 
PDZ proteins take part in assembling higher order clusters. For an overview of ephrinB 
interactors, please refer to Figure 4. 
 
Figure 4  EphrinB reverse signalling 
1. Stimulation and clustering of ephrin by Eph (not 
depicted) recruit src-family kinases (SFK). Tyrosine 
phosphorylation by SFKs allows Grb4 to bind via 
its SH2 domain and link to downstream signalling. 
2. De-phosphorylation of ephrinB by PTP-BL 
initiates a switch to PDZ-dependent signalling as 
proposed by Palmer et al, 2002. 
Phospho-tyrosines represented by green circles, 
PDZ-binding motif at the very C-term of ephrinB 
in orange, as are PDZ -interactors. 
SFK (src family kinases, cytoplasmic tyrosine 
kinases), Grb4 (growth-factor receptor-bound 4, 
a SH2/SH3 adaptor), GRIP1/2 (glutamate 
receptor interacting protein, a seven PDZ domain 
scaffolding molecule), Syntenin (a synaptic, membrane-organising molecule), FAP-1 (Fas-
associated protein-tyrosine phosphatase 1), PICK1 (protein interacting with C kinase, 
cytoplasmic adaptor), PHIP (pleckstrin homology domain interacting protein), PDZ-RGS 
(Regulator of G protein Signaling), PTP-BL (Protein tyrosine phosphatase Burkitts lymphoma). 
 
 
Similar to the conformational changes undergone by activated Eph receptors, it has also 
been proposed that upon stimulation, the B-class ephrins succumb to a structural 
rearrangement induced by tyrosine phosphorylation that serves to recruit interactors (Song, 
2003; Song et al., 2002). De-phosphorylation by PTP-BL has been shown by Klein and 
colleagues and has been speculated to act as a molecular switch mechanism between 
phospho-tyrosine dependent through SH2 adaptors and PDZ-interactor mediated signalling 
(Palmer et al., 2002) and Figure 4).  
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Analysis of the formation of the anterior commissure (AC) in mouse mutants has shown that 
the ephrinB-expressing commissural axons travel through EphB2 and EphA4 expressing 
regions. Null mutant mice for receptors and ligands involved in this process all show axon 
guidance defects. However, a rescue of this misrouting could be demonstrated by knock-ins 
of a catalytically inactive EphA4 or a C-terminally truncated EphB2. Hence the correct AC 
formation solely depends on reverse signalling of ephrinBs in the AC axons and in this case, 
Eph receptors act as “ligands” (Cowan et al., 2004; Kullander et al., 2001b; Orioli et al., 
1996).  
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1.2 Rin1 
 
In my thesis work I have investigated the role of Rin1 (Ras/Rab interactor 1) downstream of 
Eph receptors. In the following chapter I will review the current knowledge on this protein. 
Rin1 is cytoplasmic signal transducer composed of several distinct protein domains. The 
murine Rin1 protein consists of 763 amino acids (aa), including a N-terminal src-homolgy 2 
(SH2) domain, followed by a proline-rich region, a conserved 14-3-3 binding motif, a 
Rab5 guanine nucleotide exchange factor (GEF) domain and a conserved C-terminal Ras 
association (RA) domain (Figure 5).  
 
Figure 5 Rin1 domain structure 
Rin1 consists of a N-terminal (N) src-homology 2 (SH2) domain depicted in blue, multiple 
poly-proline motives (PxxP) in pink, a conserved 14-3-3 binding motif (a short stretch of aa 
including p-Serine340) depicted as a light grey bar, a Vps9p-like (Vps9p is a GEF for the 
yeast ortholog of Rab5, Vps21p) catalytic GEF domain in green and a C-terminal (C) Ras-
association (RA) domain in orange 
 
Recent identification of Rin2 (Kimura et al., 2006; Saito et al., 2002) and Rin3 (Kajiho et 
al., 2003) has made Rin1 only the first of a family of highly similar proteins to be 
discovered. In a screen for mammalian cDNAs capable of suppressing the RAS2V19 
phenotype in yeast performed by Wigler and colleagues, Rin1 was originally identified as 
clone JC99 (Colicelli et al., 1991). RAS2V19 is a point mutant of the yeast RAS2 protein, 
expression of which results in heat shock sensitivity and failure to survive prolonged nutrient 
survival (Sass et al., 1986; Toda et al., 1985). Further research demonstrated that JC99 
can interact directly with human H-Ras protein, hence it was termed Ras interaction/ 
interference 1, abbreviated Rin1 (Han and Colicelli, 1995), an acronym which is currently 
listed in NCBI as Ras/Rab interactor 1. The same study also showed that Rin1 interacts most 
strongly with GTP-bound Ras, whereas it failed to bind to an effector domain mutant of Ras 
(H-RasL35R37) and a dominant negative form (H-RasA15). It directly competes with the known 
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Ras effector Raf1 in vitro, thus the authors proposed Rin1 as a novel effector or regulator 
of H-Ras (Figure 6). Research from this laboratory later determined that Rin1 can interfere 
with transcriptional activation dependent on the Ras-MAPK cascade, that in addition, it 
interacts with 14-3-3 isoforms epsilon, beta and zeta and that Rin1 binds to and is a 
substrate for c-ABl (Han et al., 1997). Rin1 is able to rescue BCR-ABL mutants for 
transformation, a phenomenon which  depends on tyrosine phosphorylation of Rin1 and its 
binding to Abl-SH2 and SH3 domains through its poly-proline motives (Afar et al., 1997), 
(Figure 6). More recent work revealed that Rin1 is able to induce Abl2 (Arg) catalytic 
activity, which results in enhanced phosphorylation and thus inhibition of the cytoskeletal 
regulators CRK (chicken retroviral kinase) and CRKL (Crk-like) and a block of cell migration 
(Hu et al., 2005).  
 
The focus of Rin1 research however, has become the ability of Rin1 to act as a GEF for the 
small GTPase Rab5 (for further information about Rab5, please refer to chapter 1.3.1). It 
had been known previously that activated alleles of Rab5A or Rab5A overexpression can 
stimulate EGFR internalisation and fluid phase endocytosis (Barbieri et al., 2000) and that 
also overexpression of Ras can enhance the latter process (Bar-Sagi and Feramisco, 1986). 
Earlier work had also determined that potentiation of endocytosis by Ras seems to occur 
upstream of Rab5 (Barbieri et al., 1998), though it had remained unclear how this is 
achieved.  Horazdovsky and colleagues then showed that Rin1 is able to stimulate Rab5 
guanine nucleotide exchange, Rab5A dependent endosome fusion and EGFR endocytosis, 
all of which is potentiated by activated Ras (Tall et al., 2001). Thus, the authors proposed 
Rin1 as an integrator of cell signalling and endocytosis that physically links the signalling 
GTPase Ras to the membrane trafficking GTPase Rab5. Further mechanistic insight was 
provided by a study on the molecular interaction of Rin1 and EGFR. It demonstrated that 
the SH2 domain of Rin1 mediates direct interaction with the activated, tyrosine-
phosphorylated EGFR receptor and that Rin1 was rapidly recruited to the plasma 
membrane and endosomes upon EGF stimulation (Barbieri et al., 2003).  
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Figure 6 Schematic representation of 
Rin1 interactions 
It has been shown that Rin1 binds via 
its SH2 domain to the activated 
EGFR (Epidermal Growth Factor 
Receptor, phospho-tyrosines as 
yellow circles), and enhances EGFR 
endocytosis via activation of Rab5, 
a feature which is enhanced by 
concomittant binding of activated 
Ras (rat sarcoma, GTPase). Rin1competes with Raf (RAF proto-oncogene serine/threonine-
protein kinase) for the binding to Ras and thus blocks (or diverts the signalling outcome away 
from) the canonical Ras-Raf-MAPK (mitogen activated protein kinase) pathway. Rin1 binding 
to Abl (Abelson kinase) has been shown to affect cytoskeletal regulators Crk and CRKL 
(chicken retroviral kinase and Crk-like).  
 
Furthermore it was shown that Rin1 can also interact with other RTKs, such as Insulin Receptor 
(IR), Platelet-Derived Growth Factor Receptor (PDGFR) and Fibroblast Growth Factor 
Receptor-II (FGFR-II) through its SH2 domain (Barbieri et al., 2003). A recent publication 
elaborated on the interaction between Rin1 and IR showing that Rin1 can both enhance IR 
internalisation as well as regulate known IR signal transduction pathways (Hunker et al., 
2006b). 
The in vivo biological relevance of Rin1 in mice was addressed in a knock-out approach by 
Colicelli and colleagues (Dhaka et al., 2003). This group described a prominent expression 
of Rin1 in dendrites of mature forebrain neurons, a place where Rin1 also interacts with 
endogenous Ras. Rin1-/- mice are viable, fertile and appear to develop normally. When 
examining plasticity in the adult brain however, they could show elevated amygdala LTP, 
enhanced fear conditioning and elevated conditioned taste aversion in null mutants 
compared to wt littermates. Hippocampus-dependent learning and LTP, as well as motor 
learning, anxiety and exploratory behaviour, on the other hand, were unaffected in knock-
out animals (Dhaka et al., 2003). 
 
Rørth and colleagues discovered a homologue of Rin1 in Drosophila in 2001 and called it 
sprint, for SH2, poly-proline containing Ras interactor (Szabo et al., 2001). They described 
two isoforms, sprint-a and sprint-b with temporally distinct expression patterns suggesting 
unique functions for the two proteins. The same laboratory recently inplicated Sprint as a 
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regulator of endocytosis involved in modulating RTK signalling in guided migration (Jekely 
et al., 2005). Migration of border cells during Drosophila oogenesis is guided by two RTKs, 
EGFR and PVR (the Drosophila PDGF/VEGF receptor) that respond to their respective 
oocyte-expressed ligands, Gurken and PVF1 (Duchek and Rorth, 2001; Duchek et al., 
2001). It was demonstrated however, that a mere increase in EGFR and PVR signalling did 
not perturb the correct migration whereas only about 50% of border cells mutant for Cbl 
(Casitas B-lineage lymphoma) correctly reached their target. This effect was supressed by 
reducing the amount of the EGFR ligand Gurken and strongly enhanced by overexpression 
of EGFR and PVR in Cbl mutant background arguing that the Cbl phenotype resulted from 
excessive misregulated signalling (Jekely et al., 2005). Given the biochemical function of 
Cbl as an E3 ubiquitin (Ub) ligase involved in endocytosis, downregulation and Ub-
mediated degradation of RTKs (Thien and Langdon, 2001), the authors furthermore 
investigated whether Hrs, an endosome-associated, Ub-binding protein required for 
degradation of RTKs (Raiborg et al., 2002), would have an effect of border cell migration. 
Hrs mutant cells showed an accumulation of signalling active EGFR and PVR; in spite of this 
increase in signalling though, the migration was not significantly impaired, confirming the 
effect seen in border cells overexpressing EGFR and PVR (Jekely et al., 2005). Since the 
Cbl phenotype showed incomplete penetrance, the authors investigated the role of Sprint 
and found that when challenged by overexpression of the relevant RTKs, Sprint mutant 
border cells displayed significant migration defects.  Cells mutant for both Cbl and Sprint 
rarely reached the oocyte suggesting a synergistic role of the two proteins acting in 
parallel to regulate the same process. Finally, RTK activity in the migrating border cells was 
shown to be restricted to the leading edge of the cells (as judged by phospho-tyrosine 
stainings) where also Sprint localises, an effect that was abolished in Cbl mutants (Jekely et 
al., 2005). The requirement for Cbl and Sprint suggested that the cellular activity required 
for signal restriction is RTK endocytosis, which was supported by the result of dominant 
negative shibire (dynamin) expression which also affected correct migration. Thus in this 
physiological context of guidance by RTKs, endocytosis serves not to downregulate active 
receptors but to ensure their correct spatial localisation. Figure 7 shows an explanatory 
model proposed by the authors that integrates the aforementioned data.  
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Figure 7 Maintenance of localised EGFR and PVR signalling by Cbl and Sprint in Drosphila 
border cell migration 
1. The diffusible ligands Gurken and PV1 from the oocyte bind to their respective receptors 
EGFR and PVR in the migrating border cells and activate them. 
2. Lateral movement of activated receptors or spreading of RTK activation in the membrane 
would de-localise the signal as has been described for ErbB1 (Verveer et al., 2000), and thus 
needs to be prevented for correct guidance. 
3. Cbl and Sprint could spatially restrict the activated receptors by sequestering them in coated 
pits which would lead to a localised signalling output at the leading edge of the migrating 
cells. 
4. The potential degradation of endocytosed PVR and EGFR does not seem a satisfactory 
explanation for the phenomena observed as data by Jékely et al. showed that no significantly 
increased levels of RTK signalling were observed in Cbl or Sprint mutants yet migration was 
severely perturbed. 
5. Prior endocytosis of active RTKs proceeds to a local regulated recycling or redelivery 
leading to in increase in spatially restricted signalling output. 
Inactive RTK are depicted in grey, ligand activated receptors shown in purple. Adapted from 
Jékely et al., 2005 
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1.3 Endocytosis 
 
As explained in the previous chapter, one of the most prominent functions of Rin1 is its role 
in endocytosis as a Rab5 GEF. In the work presented here I studied the role of Rin1 in the 
endocytosis of EphA4 receptor. Therefore I will point out the basic principles of endocytosis, 
the most important molecules involved and examples for the biological relevance of 
endocytosis in the following paragraphs. 
Endocytosis (from greek endon meaning within, kytos/cytos meaning hollow vessel = the cell 
and -osis meaning condition, process or state) is a means by which cells regulate nutrient 
uptake, plasma membrane composition and signal transduction. However, recent data 
shows that different endocytic pathways serve to integrate diverse signals, hence 
contributing to a higher level of cellular organisation (Polo and Di Fiore, 2006). Endocytosis 
of receptor-ligand complexes was initially thought to serve solely the purpose of 
attenuating signalling by removing said complexes from the plasma membrane and 
targeting them for degradation. The cellular machinery however, achieves a high order of 
regulation by exploiting the compartmentalisation and functional specialisation of the 
endocytic pathway, going beyond its conventional role in cargo degradation. Endosomes 
are specialised endocytic organelles that are ideally suited for such regulation as they are 
organised into a network of physically and biochemically distinct membranous domains, 
interconnected by a tightly controlled transport system (Gruenberg, 2001; Miaczynska and 
Zerial, 2002; Pfeffer, 2003; Zerial and McBride, 2001). The dynamic identity and 
functional diversity of endosomes is driven by finely choreographed mechanisms that 
rapidly recruit small GTPases, phosphatidylinositol lipids and various secondary effectors to 
these organelles (Miaczynska et al., 2004). Furthermore they are interconnected with 
biosynthetic routes and secretory pathways thereby expanding their role beyond endocytic 
organelles (Perret et al., 2005). The plasma membrane was considered the exclusive 
location of signalling until Bergeron, Posner and colleagues observed that shortly after 
ligand addition the majority of activated epidermal growth factor receptors (EGFRs) and 
their downstream signal transducers such as Shc, Grb2 and mSOS were found on early 
endosomes instead of the plasma membrane (Di Guglielmo et al., 1994). The same 
laboratory furthermore suggested that EGFR signalling continues from this compartment 
(Baass et al., 1995). Subsequent demonstration that nerve growth factor (NGF) was bound 
to its activated receptor TrkA and phospholipase C-γ1 (PLC-γ1) in endocytic organelles 
(Grimes et al., 1996) led to the ‘signalling endosome’ hypothesis. This hypothesis has been 
further supported recently by two groups investigating the role of retrograde transport of 
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internalised receptor-ligand complexes in endosomes of sympathetic neurons. Mobley and 
colleagues could demonstrate that upon nerve growth factor (NGF) treatment of distal 
neuronal processes, NGF-engaged TrkA, along with activated downstream effectors such as 
Erk1/2 and Akt, co-localises with Rab5 and EEA1 (early endosome antigen 1) on 
endosomes in axons and cell bodies (Delcroix et al., 2003). Furthermore, the accumulation 
of retrogradely transported NGF-TrkA complexes in cell bodies is required for neuronal 
survival whereas stimulation of the soma with NGF was not sufficient (Riccio et al., 1997; Ye 
et al., 2003). 
It has long been known that there are several different endocytic routes; the biological 
relevance of this, however, is still poorly understood. Characteristics of the four main routes 
of endocytosis, namely caveolar/raft mediated endocytosis (CRE), clathrin-mediated 
endocytosis (CME), phagocytosis (from greek “phagein”, to eat) and macropinocytosis (from 
greek “pinein”, to drink) are shown in Figure 8. 
 
 
 
Figure 8 Endocytic routes in eukaryotic cells 
1. Caveolar/Raft mediated Endocytosis: 
Proteins resident in lipid rafts (LR) like GPI-anchored molecules or membrane receptors 
recruited to raft microdomains can be internalized in this clathrin-independent pathway. After 
initial uptake from caveolae (CAV), proteins reach specialised vesicles known as caveosomes 
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(CS), from which GPI-anchored cargo can traffic to the Golgi complex (trans-Golgi network, 
TGN). Invaginations are usually characterized by the presence of caveolin1/2 but, in absence 
of caveolins, internalisation from rafts has also been observed. GPI-linked molecules subject to 
this clathrin- and caveolin-independent from of endocytosis then traffic to the GPI-anchored 
protein-enriched early endosomal compartment (GEEC, not depicted in the scheme), from 
where they can continue to recycling endosomes (RE). Mechanisms regulating this pathway are 
unclear. 
2. Clathrin-Mediated Endocytosis: 
Receptor-ligand complexes are internalised to early endosomes (EE) or sorting endosomes 
(SE), from which they reach either late endosomes (LE), compartments committed to the 
degradative route to lysosomes (LY), or recycling endosomes (RE), from where they can traffic 
back to the cell membrane 
3. Phagocytosis: 
Specialised cells such as macrophages, monocytes and neutrophils clear debris and pathogens 
by phagocytosis. A rearrangement of the cytoskeleton allows engulfment of the particle. After 
internalisation, the phagosome (PH) fuses with a lysosome (LY) to form the phago-lysosome 
(PH/LY) in order to acquire the necessary hydrolytic enzymes for degradation of the cargo. 
4. Macropinocytosis: 
Stimulation with growth factors or other signals can trigger the actin-driven formation of 
membrane protrusion that fuse with the plasma membrane to form large endocytic vesicles, 
known as macropinosomes (MP). These encapsulate large volumes of extracellular fluid and 
either fuse to lysosomes or recycle back to the cell surface. 
EE (early endosome), SE (sorting endosome), LE (late endosome), RE (recycling endosome), 
MP (macropinosome), CCP (clathrin coated pit), LR (lipid raft), CAV (caveolae), CS 
(caveosome), PH (phagosome), LY (lysosome), PH/LY (phago-lysosome), TGN (trans-Golgi-
network), MVP (multivesicular body) adapted from Miaczynska et al., 2004 and Perret et 
al., 2005  
 
 
Clathrin-mediated endocytosis (CME) is the best-studied pathway so far, so named for the 
clathrin triskelion lattice found on membrane invaginations (Clathrin-coated pit, CCP) and 
vesicles (clathrin-coated vesicle, CCV) (Bonifacino and Lippincott-Schwartz, 2003; 
Kirchhausen, 2000). The original concept that CME involves a common mechanism for a 
variety of receptors has been quickly replaced by a new scenario where different 
receptors utilize highly individualized endocytic mechanisms. Novel imaging techniques 
helped reveal the sequential recruitment of accessory and scaffolding proteins (e.g. AP2, 
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epsin, dynamin, actin and ARP2/3) during CCV formation (Conner and Schmid, 2003; 
Merrifield, 2004; Rappoport et al., 2004) and receptor-specific requirements for certain 
molecules of the endocytic machinery have been demonstrated (Motley et al., 2003).  
 
Clathrin-independent forms of endocytosis however, also play important roles. One of 
these, the caveolar/ raft endocytosis (CRE), relies on cholesterol-rich membrane domains, 
namely lipid rafts and flask-shaped invaginations called caveolae. Although it was initially 
believed that caveolin, which is found on the caveolae, was an essential structural 
component in this pathway, it has been demonstrated that a form of lipid-raft endocytosis 
can occur also in absence of caveolin (Johannes and Lamaze, 2002; Parton, 2003; Sharma 
et al., 2002). The balance between caveolin-1 and raft lipids influences the rate of 
caveolar endocytosis (Sharma et al., 2004) and caveolin overexpression can inhibit certain 
endocytic pathways (Kirkham et al., 2005; Nabi and Le, 2003). Endocytosis from plasma 
membrane caveolae, which have been shown to be stably anchored by the actin 
cytoskeleton (Stahlhut and van Deurs, 2000; Thomsen et al., 2002) proceeds to a 
compartment termed caveosome (Pelkmans and Helenius, 2002) or to the early endosome.  
 
An important insight from recent studies is that the route of entry into the cell may also 
determine the ultimate fate of the ligand–receptor complex. At low ligand levels, EGFR is 
internalized as a functional signalling receptor by CME, whereas at high EGF 
concentrations, EGFR is (mono)-ubiquitinated, after which it is internalized by a lipid 
raft/caveolar mechanism and subsequently degraded (Chen and De Camilli, 2005; 
Sigismund et al., 2005). Interestingly, this concept of differential routes affecting functional 
outcome has also been observed for transforming growth factor-ß receptor (TGF-ß R). 
Wrana and colleagues could show that internalisation of TGF-ß R via CCPs leads to signal 
propagation whereas CRE results in signal termination (Di Guglielmo et al., 2003). It has 
been hypothesised that compartmentalisation, i.e. plasma membrane versus endosomes or 
CME versus CRE provides an additional means by which cells regulate signalling (Polo and 
Di Fiore, 2006).  
 
Phosphatidylinositol lipids (PIs) or phosphoinositides are key components of membranes that 
are distributed along the endocytic pathway in a spatially and temporally restricted 
manner. As a result of the activities of specific PI kinases and phosphatases, PIs are 
produced and consumed at regions of high membrane curvature where fusion or fission of 
vesicles can occur (De Matteis and Godi, 2004). A key role of PIs is to recruit proteins 
containing PI-binding modules such as the epsin-N-terminal-homology (ENTH) domain, 
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pleckstrin homology (PH) or PHOX homology (PX) domains and the FYVE motif. Early-
endosome antigen 1 (EEA1), for example is recruited to Phosphatidylinositol-3 Phosphate 
(PtdIns3P) which is highly abundant in and specific to the early endosome membrane via its 
FYVE domain (Le Roy and Wrana, 2005). 
 
Components of the cytoskeleton, e.g. actin and microtubules, have also been shown to play 
important roles in endocytosis (Apodaca, 2001; da Costa et al., 2003; Kaksonen et al., 
2006) as have cytoskeletal regulators such as Rac (Cowan et al., 2005; Marston et al., 
2003). Microtubule-dependent motors function at various stages in the endocytic pathway 
and dynamic interaction between plus- and minus-end-directed motors influences the 
steady-state intracellular distribution of endosomes (Fan et al., 2004; Hoepfner et al., 
2005). 
 
 
1.3.1 Rab proteins in endocytosis 
 
Human cells express more than 60 different Rab-GTPases, members of the Ras GTPase 
family that are involved in transport-vesicle formation, motility, docking and fusion (Pereira-
Leal and Seabra, 2001; Pfeffer, 2001; Segev, 2001; Zerial and McBride, 2001). Like all 
GTPases they shuttle between an active, GTP-bound and an inactive, GDP-bound state. 
Transition from inactive to active is facilitated by guanine nucleotide exchange factors 
(GEFs), whereas inactivation is achieved through GTPase-activating proteins (GAPs). Rabs 
are membrane-associated via their C-terminal prenylations and bind to other membrane-
associated proteins there. They are, however, also found in the cytosol, bound to the GDP-
dissociation inhibitor GDI (Alory and Balch, 2001). Figure 9 presents a scheme of a few 
Rab proteins involved in the endocytic pathway. Zerial and colleagues have proposed a 
model by which Rab proteins act as membrane organizers (Christoforidis et al., 1999b; 
Sonnichsen et al., 2000; Zerial and McBride, 2001) a concept which shall be exemplified 
here for Rab5. 
Rab5 is regulated by GEFs, such as Rab5-activating protein 6 (RAP6) (Hunker et al., 
2006a), Rabex-5 (Horiuchi et al., 1997), Ras/Rab interactor 1 (Rin1, see also chapter 1.2) 
(Tall et al., 2001), Rin2 and Rin3 (Kajiho et al., 2003; Saito et al., 2002), Alsin (Topp et al., 
2004) and GAPs, such as RNtre (Matoskova et al., 1996) . In its active GTP-bound state, 
Rab5 interacts with a variety of effectors. One of these, the type III PI3K (hVPS34/p150) is 
recruited to the Rab5 domain on the early endosome (EE) leading to a local production of 
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PI3P in the EE membrane which thus serves as a docking site for Rab effectors that contain a 
FYVE motif, such as EEA1 (Christoforidis et al., 1999a). In compartments devoid of the type 
III PI3K such as clathrin-coated vesicles (CCVs) or the plasma membrane, the FYVE-finger 
containing Rab5 effectors are not recruited despite the presence of active Rab5 (Rubino et 
al., 2000). Furthermore, some Rab5 effectors form oligomeric complexes with components 
of the SNARE machinery, hence the Rab5 domain on EEs seems to be involved mainly in 
endosome docking and fusion (McBride et al., 1999). The formation of the Rab5 domain 
depends on the cooperative action of several membrane constituents. In the case of Rab5 
and possibly other Rab proteins, the binding of effectors and the presence of exchange 
factors in the effector complexes (Lippe et al., 2001) may initiate a positive feedback loop 
that amplifies the recruitment and the activation of the GTPase.  
 
 
Figure 9 Rab proteins and Rab domains in the endocytic pathway  
Intracellular compartments of the endocytic route are characterised by the distinct composition 
of Rab proteins in their membranes. For details please refer to the text. PM (plasma 
membrane), LR (lipid raft), CAV (caveloae), CCP (clathrin-coated pit), TGN (trans-Golgi 
network). Adapted from Miaczynska and Zerial, 2002 
 
The proposal that Rab proteins and their effectors can be restricted to specialized 
membrane domains received further support from the morphological analysis of the 
distribution of Rab proteins in early and recycling endosomes (Sonnichsen et al., 2000) 
(Figure 9). Despite a significant degree of colocalisation within the same organelle, 
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different Rabs occupy separate areas on the membrane, forming domains that exhibit 
different pharmacological sensitivity and are in a dynamic equilibrium with each other. 
Early endosomes appear mainly composed of Rab5 and Rab4 domains, with a smaller 
proportion of Rab11-positive regions. In contrast, recycling endosomes are enriched in 
Rab11 and Rab4 domains (Sonnichsen et al., 2000). Several other Rab proteins have also 
been localized to compartments of the early endocytic pathway, such as Rab15, Rab18, 
Rab20, Rab22, and Rab25 (Somsel Rodman and Wandinger-Ness, 2000; Zerial and 
McBride, 2001). Late endosomes are characterized by the presence of Rab7 and Rab9 
(Somsel Rodman and Wandinger-Ness, 2000). Rab7 regulates transport between early 
and late endosomes, whereas Rab9 governs the formation of carriers destined for the TGN 
(Figure 9). 
 
 
1.3.2 The biological relevance of endocytosis 
 
Although the phenomenon of endocytosis has been studied for a long time, reports 
demonstrating its essential contribution during developmental processes in living organisms 
have only accumulated during recent years. Researchers have tampered with molecules of 
the endocytic pathway to uncover their important functions in vivo. 
A number of studies have focussed on the trafficking of the cell adhesion molecule E-
cadherin. Eaton and colleagues could show that in Drosophila wing development, the planar 
cell polarity pathway (PCP) regulates the arrangement of wing epithelial cells by 
controlling the trafficking of E-cadherin. They found E-cadherin to colocalise with Rab11 in 
recycling endosomes indicative of its endocytosis and recycling and to accumulate there 
when a dominant negative form of Rab11 was used. By blocking endocytosis with a 
temperature sensitive allele of shibire (the Drosophila Dynamin homologue), epithelial cell 
rearrangement was abrogated. The protocadherin Flamingo, which is part of the PCP 
pathway, is thought to recruit the exocyst component Sec5 to distinct membrane areas to 
redirect the delivery of E-cadherin. Thus, the authors demonstrated that endocytosis and 
regulated redelivery of E-cadherin is necessary for the morphological transition undergone 
by wing disc epithelial cells during metamorphosis (Classen et al., 2005). Similarly, E-
cadherin endocytosis was proposed to destabilise certain cell junctions to allow for cell 
intercalation during Drosophila germband extension, a morphogenetic event in gastrulating 
embryos during which an epithelial sheet doubles its length and reduces its width by half 
(Bertet et al., 2004; Lecuit, 2005). Also in Zebrafish gastrulation, E-cadherin endocytosis is 
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important for the directed migration of mesendodermal cells that lead to the formation of 
the prechordal plate. Silberblick, the Zebrafish wnt11 homologue which is an essential 
regulator of zebrafish gastrulation (Heisenberg et al., 2000; Ulrich et al., 2003), was 
recently shown to determine the amount of E-cadherin at the plasma membrane by 
directing its endocytic trafficking (Ulrich et al., 2005). Interfering with endocytosis by use of 
a dominant negative form of Dynamin or morpholinos against Rab5 or its GAP, RNtre, 
resulted in a phenotype which resembles that of wnt11 mutants, whereas expression of an 
activated form of Rab5 can rescue the wnt11 phenotype (Ulrich et al., 2005). 
In Drosophila embryos, the distribution of wingless (Wnt-1 homologue) changes from 
symmetrical to asymmetrical at stage 10 in a regulated fashion (Couso et al., 1993; Sanson 
et al., 1999). This transition is achieved by endocytosis and lysosomal degradation of 
wingless at the posterior end of each stripe of its expression domain. This is partly due to 
the segmental activation of signalling by the EGFR, which accelerates wingless degradation 
at the posterior end, thus leading to asymmetrical wingless signalling along the anterior-
posterior axis (Dubois et al., 2001). Also for Decapentaplegic (Dpp), the Drosophila TGF-ß 
homologue, it has been shown that endocytosis is integral for generating a gradient in wing 
imaginal discs (Entchev et al., 2000). 
Regulated internalisation has not only been shown to be important for cell adhesion 
molecules and soluble ligands or morphogens but also for receptor tyrosine kinases. Rørth 
and colleagues recently demonstrated that Cbl and Sprint, the Drosophila homologue of the 
Rab5 GEF Rin1, synergistically regulate EGFR and PVR signalling in border cell migration 
during Drosophila oogenesis (Jekely et al., 2005), an example which is discussed further in 
chapter 1.2.  
 
 
1.3.3 Trans-Endocytosis of transmembrane molecules 
 
Endocytosis of protein complexes mediated by trans-interaction of two transmembrane 
proteins has rarely been documented in the literature (Sorkin and Von Zastrow, 2002). 
Trans-endocytosis in a unilateral fashion has been described in Drosophila, where the 
transmembrane ligand Bride of Sevenless (Boss) is internalised via its receptor Sevenless 
(Sev) into R7 photoreceptor cells (Cagan et al., 1992). Endocytosis of a membrane tethered 
form of Sonic Hedgehog by its receptor Patched has also been observed, again only in a 
unidirectional manner (Incardona et al., 2000). One well studied example that bears 
similarity with the Eph-Ephrin system though is that of the Notch receptor and its ligands, 
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DSL (for Delta and Serrate from Drosophila and Lag2 from C. elegans; Jagged is the 
homologue in vertebrates). 
 
 
The Notch-Delta system 
 
For comprehensive reviews on Notch signalling and Notch in endocytosis please refer to (Le 
Borgne, 2006; Schweisguth, 2004). Notch is a single-pass transmembrane protein, 
originally identified in Drosophila that mediates many developmental signalling events, such 
as lateral inhibition and binary cell fate decisions (Radtke et al., 2005). Signalling by Notch 
receptor involves three successive cleavages, the last of which is performed by Presenilin 
and releases the Notch intracellular domain which translocates to the nucleus where it acts 
as a transcriptional co-activator (Fortini, 2001).  
Endocytosis is required for Notch activation in both the receptor-expressing as well as the 
ligand-expressing cell (Seugnet et al., 1997). Although Dynamin and the ubiquitin ligase 
Deltex seem to be involved (Hori et al., 2004; Seugnet et al., 1997), endocytosis in the 
Notch-expressing, signal-receiving cell is not fully understood. Somewhat contradictory 
results suggest though that Notch endocytosis might also have an inhibitory function. In wt 
epithelial cells, Notch is endocytosed through a Rab5 -dependent pathway (Lu and Bilder, 
2005) and targeted for degradation by the ESCRT complex. However, mutations of the 
Drosophila homologues of ESCRT-complex members result in accumulation of Notch in 
endosomes and concomitant overactivation (Moberg et al., 2005; Thompson et al., 2005; 
Vaccari and Bilder, 2005). 
The asymmetric division of Drosophila sensory organ precursors (SOP) has emerged as a 
successful model for the analysis of Notch signalling in a developmental context. After SOP 
division, Notch and Delta are present in both daughter cells, but differential regulation of 
endocytic trafficking ensures that Notch signals in the future pIIa but not the pIIb cell 
(reviewed in (Emery and Knoblich, 2006)). In the ligand-expressing cell, endocytosis plays 
an activating role. The ubiquitin ligases Neuralized (Neur) and Mind bomb (Mib) are 
involved in Delta endocytosis and are required for the ligand to activate Notch on 
neighbouring cells (Lai et al., 2005; Le Borgne et al., 2005; Wang and Struhl, 2005). Other 
authors have suggested that Delta needs to be endocytosed and recycled through Rab11 
endosomes before it becomes competent to activate Notch (Emery et al., 2005; Wang and 
Struhl, 2004; Wang and Struhl, 2005). A third way to ensure Notch signalling in the pIIa 
but not the pIIb cell is achieved through Numb, which after SOP division is specifically 
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inherited by pIIb. Numb has been shown both to bind to Notch, as well as α-adaptin, an 
important molecule in early endocytic events (Berdnik et al., 2002). A novel four-
transmembrane molecule, Sanpodo (Spdo) has recently been identified as an important 
regulator of Notch signalling and shown to bind to both Numb and Notch (Hutterer and 
Knoblich, 2005; O'Connor-Giles and Skeath, 2003). In the pIIb cell and in the presence of 
Numb, it co-localises with Notch, Rab5 and Rab7 (Hutterer and Knoblich, 2005), indicative 
of trafficking to the late endosomal, possibly degradative pathway.  
 
 
Endocytosis of Ephs and ephrins 
 
Despite the fact that Notch and Delta are both transmembrane molecules, can both elicit 
signalling and are endocytosed in their respective cells, a number of facts still make the 
Eph-Ephrin system unique. Most importantly, although there is evidence that the Notch 
extracellular domain can be trans-endocytosed by the delta-expressing cell (Parks et al., 
2000), it is not the entire receptor which can be engulfed by the signal-sending cell. Data 
concerning the endocytosis of Ephs and ephrins has come out of only very few studies 
(Cowan et al., 2005; Marston et al., 2003; Parker et al., 2004; Zimmer et al., 2003). The 
EphB2 receptor has recently been linked to clathrin-mediated endocytosis in cultured cells 
and cultured rat hippocampal neurons. Yamaguchi and colleagues demonstrated that 
ephrinB2-stimulated EphB2 phosphorylates the phosphatidylinositol 5’-phosphatase 
synaptojanin 1 and inhibits thus both the interaction with endophilin and the 5’-phosphatase 
activity of synaptojanin 1 (Irie et al., 2005). They further showed an increase in transferrin 
uptake in cultured cells as well as GluR1 internalisation in cultured neurons, both of which 
processes depended on EphB2 kinase activity and Synaptojanin phosphorylation. Even 
though these results are intriguing they did not elucidate the endocytosis of the Ephs and 
ephrins themselves. 
Greenberg and colleagues demonstrated that during growth cone guidance ephrinA1-
mediated activation of EphA4 leads to Vav-dependent endocytosis of the ligand-receptor 
complex. Vav family proteins are Rho GEFs that induce membrane ruffles and lamellipodia 
as well as strongly activate Rac family GTPases in mammalian cells (Arthur et al., 2004; 
Kawakatsu et al., 2005; Liu and Burridge, 2000; Marcoux and Vuori, 2003; Marignani and 
Carpenter, 2001; Schuebel et al., 1998; Servitja et al., 2003; Tamas et al., 2003). In the 
absence of Vav proteins, there is no detectable endocytosis of ephrinA1 into Eph-
expressing retinal ganglion cells (RGCs) whereas internalisation of transferrin seemed 
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unaffected (Cowan et al., 2005). They furthermore showed that Vav2/Vav3 double 
knockout mice display abnormal retinogeniculate projections, indicating an important role 
for Vav proteins in the formation of the ipsilateral retinogeniculate map, possible due to 
regulation of ephrin-Eph mediated axon guidance (Cowan et al., 2005).  
 
A few years ago, two groups independently discovered the phenomenon of bi-directional 
trans-endocytosis in the Eph-ephrin system (Marston et al., 2003; Zimmer et al., 2003). 
Work from both laboratories proposed the process as an underlying mechanism that 
mediates repulsion between Eph receptor and ephrin ligand expressing cells. Nobes and 
colleagues microinjected adjacent rows of fibroblast cells in a confluent culture with EphB4 
and its ligand ephrinB2 and analysed their interaction using time-lapse microscopy. Ligand 
and receptor cells in contact retracted from one another, concomitant with endocytosis of 
the activated receptor and its bound, full-length ligand into the Eph-expressing cell. Similar 
results were observed with primary human umbilical vein endothelial cells (HUVECs) that 
endogenously expressed EphB4 when challenged with ligand expressing cells. 
Internalisation and retraction were shown to depend on Rac-signalling and elicited actin 
polymerisation. 
EphB4 and ephrinB2 had been shown previously to act as a receptor-ligand pair triggering 
repulsive cell responses. They are expressed during vascular development in venus and 
arterial endothelial cells respectively, and are necessary to maintain the boundary between 
the two types of endothelial cells (Adams and Klein, 2000). Interestingly, Nobes and 
colleagues could also detect EphB4-positive vesicles in the ligand-expressing cell; this 
however, was only observed in a small proportion of the examined cases. The trans-
endocytosis of EphB4 into ephrinB2 cells could be enhanced by expressing a truncated 
version lacking the kinase-domain of the receptor from a mean 10% with full-length EphB4 
to 37% with the mutant EphB4 (Marston et al., 2003). 
 
Klein and colleagues used fibroblasts expressing the EphB2 receptor or ephrinB1 ligand in 
cell-cell stimulation assay where the “recipient” cells expressing either the receptor or the 
ligand were presented with “stimulator” cells seeded on top and expressing the respective 
counterpart (Zimmer et al., 2003). They could observe both ephrinB1 being internalised as 
a full-length protein into recipient EphB2 cells as well as the full-length receptor being 
transferred to recipient ligand-expressing cells. Similar results were obtained by time-lapse 
imaging of axonal growth cones (of primary cortical neurons) that were challenged with 
HeLa cells expressing either a fluorescently tagged ephrinB1 or EphB2. Contact by the 
growth cone resulted in growth cone collapse and retraction concomitant with trans-
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endocytosis (Zimmer et al., 2003). To gain insight into the underlying molecular 
determinants of this process, Klein and colleagues interfered with the cytoplasmic portions 
of either EphB2 or ephrinB1 and studied ensuing endocytic processes (for an illustration 
please see Figure 10 ). When both partners come in contact as full-length proteins, short-
term (10 min) trans-endocytosis primarily occurs into the recipient ligand cell, in analogy to 
“reverse” signalling termed “reverse” endocytosis, after 60 min though ephrinB1 has also 
been trans-endocytosed to the stimulator EphB2 cell, termed forward endocytosis. Recipient 
cells expressing a cytoplasmically truncated ephrinB1 (ephrinB1ΔC) were unable to 
transcytose EphB2 whereas the ephrinB1ΔC was readily transferred to the receptor cell. A 
truncated receptor was equally incapable of mediating trans-endocytosis and the balance 
after 60 min was now shifted into the ephrinB1 expressing stimulator cell. Similar results 
were obtained for a kinase-dead version of EphB2. Figure 10 gives a summary of the 
bidirectional endocytosis events and subsequent cellular responses obtained with different 
receptor or ligand mutant proteins.  
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Figure 10  Bidirectional endocytosis of EphB2 receptor and ephrinB1 ligand 
Zimmer et al proposed a “tug-of-war” model for the trans-interaction and ensuing endocytosis 
of receptor and ligand in which cytoplasmic determinants influence the direction in which the 
trans-endocytosis occurs. Eph receptor molecules in green, Eph-expressing cells in light green, 
ephrins depicted in pink, ephrin-expressing cells in light pink; direction of the TE is indicated by 
arrows, sizes of arrows are indicating the relative strength of the endocytic force of the 
respective partner cell. (A) Wt EphB2 trans-endocytoses wt ephrinB1 more efficiently than vice 
versa. The cellular response is retraction of the EphB2 cell. (B) A cytoplasmically truncated 
EphB2 receptor cannot endocytose ephrinB1; cells in contact neither show adherence nor 
repulsion and behave like untransfected controls. (C) Like the truncated receptor, a kinase-
dead version of EphB2 cannot endocytose ephrinB1. Cellular response was not determined. (D) 
A truncated ephrinB1 was strongly trans-endocytosed into the EphB-expressing cell which 
responded with an even stronger (than in the case of wt ephrinB1) retraction. (E) When both 
interaction partners are compromised in their signalling capabilities by cytoplasmic truncations, 
neither side is able to endocytose and cells display strong adherence with prominent fascicles 
between them. 
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1.4 Synaptic Plasticity 
 
Both Rin1 and EphA4 have in implicated in synaptic plasticity (Dhaka et al., 2003; 
Grunwald et al., 2004), therefore the relevant information on the underlying mechansims 
and brain regions involved shall be reviewed in this chapter. Neurons are able to change 
their input-output characteristics as well as alter the  morphology of the fine structures with 
which they are connected, the synapses. These are the underlying mechanisms of plasticity 
and the basis of all learning processes in the brain. The idea that learning-induced 
modifications of the connections between neurons establish memory has already been 
proposed more than 100 years ago (Cajal, 1894;  Sherrington, 1906). Neurons are 
believed to encode memory through activity-dependent changes in the efficacy of their 
synaptic connections (Bliss and Collingridge, 1993; Martin et al., 2000). Synaptic 
connections are formed between axonal, pre-synaptic terminals and dendritic, post-synaptic 
sites (in late embryonic development through postnatal stages), a process which is called 
synaptogenesis (Constantine-Paton and Cline, 1998). Once formed, a synapse undergoes 
activity-dependent remodelling (Katz and Shatz, 1996; Nagerl et al., 2004). Presynaptic 
axon protrusions have been demonstrated to be in contact with long and thin dendrite 
extensions called filopodia, more mature structures called spines or the shafts of dendrites 
(Fiala et al., 1998; Miller and Peters, 1981). Filopodia are highly motile structures thought 
to serve as “probes” that make contact with the axon, and thus implicated in 
synaptogenesis, and have also been proposed as precursors of mature mushroom-shaped 
spines (Bonhoeffer and Yuste, 2002; Harris, 1999; Ziv and Smith, 1996). 
Spine development is regulated through signals that target rearrangements of the actin 
cytoskeleton (Bonhoeffer and Yuste, 2002; Matus et al., 2000), such as the EphB2 receptor 
through activation of the Rho GEFs Kalirin (GEF for Rac1) (Penzes et al., 2003) and 
Intersectin (GEF for cdc42) (Irie and Yamaguchi, 2002), or by clustering and tyrosine-
phosphorylating Syndecan-2 (Ethell et al., 2001), a molecule that had previously been 
shown to regulate spine maturation (Ethell and Yamaguchi, 1999). Synapses are, through 
their pre-and post-synaptic changes flexible in both morphology and function and thus 
make for ideal “gates” that regulate the transmission of information in the brain (Harris and 
Kater, 1994; Hering and Sheng, 2001; Yuste and Bonhoeffer, 2001). In 1949, Donald 
Hebb postulated as the cellular basis of learning that simultaneous activation of a pre- and 
post-synaptic process triggers the reinforcement of the active input and thus strengthens the 
synaptic contact (Hebb, 1949). However, neuronal plasticity or the changes in efficacy of 
transmission can either be strengthened or weakened depending on the applied stimulus 
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(Malenka, 1994). The weakening of a synapse is called Long-Term Depression or LTD and 
can be elicited by prolonged low-frequency stimulation. The strengthening of synapses 
though, was demonstrated first by Bliss and Lomo in rabbit hippocampi where they were 
able to increase basic synaptic transmission for several hours by applying a brief high 
frequency stimulus (Bliss and Lomo, 1973). Hence, this phenomenon was termed long-term 
potentiation or LTP. These authors studied the first of the three major excitatory pathways in 
the hippocampus (Figure 11), the perforant path that connects neurons in the entorhinal 
cortex with the granule cells in the dentate gyrus (DG). These granule cells in turn send their 
axons to make connections to pyramidal cells in the CA3 (Cornu ammonis) region, via the 
mossy fibre pathway. Currently, the Schaffer collateral, which connects the CA3 with the 
CA1 region, is the place where hippocampal plasticity is most intensely studied. 
 
 
Figure 11 A mouse hippocampal section illustrating the three major pathways 
The neurons in the perforant pathway (in green) from the entorhinal cortex synapse on granule 
cells in the dentate gyrus (DG); the Mossy fibre pathway (in yellow) connects granule cells to 
pyramidal neurons in the CA3 (Cornu ammonis) region; and CA3 neuron axons (Schaffer 
collaterals in orange) target CA1 pyramidal cells (in pink) 
 
 
Eph receptors and ephrins have been shown to be important for LTP and LTD in the 
hippocampus, therefore i will briefly mention the implication of EphA4 since it is most 
relevant to this study. Klein and colleagues have shown that at CA3-CA1 synapses, EphA4 
only acts as an activating agent for the signalling competent, post-synaptic ephrinBs using 
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EphA4eGFP/eGFP mutant mice. The EphA4eGFP receptor cannot actively signal itself but 
nevertheless in these mice both the LTP and LTD defects displayed by EphA4-/- mice were 
rescued. The authors proceeded to speculate though that the requirement of signalling by 
either ephrins (reverse signalling) or Ephs (forward signalling) in synaptic plasticity might be 
specific for each individual pathway (Grunwald et al., 2004). 
Although the induction of LTP depends on NMDA receptors, the increase in synaptic efficacy 
is mainly due to an increase of post-synaptic membrane targeting of AMPA receptors 
(Hayashi et al., 2000). LTP and LTD, although studied most intensely in the hippocampus, 
have also been described in other structures in the brain, such as the cortex or the 
cerebellum (for reviews, please refer to (Malenka and Bear, 2004) and references therein). 
The amygdala shall be of particular interest for this study. 
The amygdala is a subcortical structure in the medial temporal lobe thought to represent an 
emotional memory system and is essential for fear learning (Fanselow and LeDoux, 1999; 
LeDoux, 2000; Maren, 2001). It is composed of several nuclei, individual clusters of neurons 
that are highly interconnected with each other. Figure 12 presents a schematic overview of 
the amygdala and the pathways underlying fear conditioning. Fear conditioning provides 
an experimental model that is most commonly used to study fear memory, a learning 
process that is much simpler and thought to be much older than spatial learning taking place 
in the hippocampus. During fear conditioning, emotional significance is attached to an 
initially biologically insignificant conditioned stimulus, e.g. a tone, when such neutral stimulus 
is paired with an aversive unconditioned stimulus, e.g. a mild foot shock (reviewed in 
(Dityatev and Bolshakov, 2005)). Projections to the lateral nucleus of the amygdala (LA) 
from sensory processing areas of the neocortex and the thalamus are involved in coding the 
emotional significance of sensory stimuli (Rogan and LeDoux, 1996). These sensory-
amygdala interactions are best understood for auditory signals. Individual LA neurons are 
thought to integrate information from both the auditory thalamus and cortex during 
emotional learning (Li et al., 1996) (LeDoux, 1986). They express both NMDA and AMPA 
receptors (R) (Farb and Ledoux, 1999), both of which have been shown to be important in 
vivo for synaptic transmission from afferents onto LA neurons. It was demonstrated by intra- 
and extracellular recordings and use of inhibitors that NMDA-R and AMPA-R are essential 
at thalamo-amygdala synapses whereas at cortico-amygdala synapses NMDA receptor 
blockage did not interfere with synaptic transmission (Li et al., 1996). 
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Figure 12 The amygdala and its pathways involved in fear conditioning 
(A) Half of a coronal section of an adult mouse brain (in situ for ephA4), boxed area 
enlarged in B. The orientation of the coronal section is indicated by the cross (D, dorsal; V, 
ventral; L, lateral; M, medial) Please note that ephA4 expression is particularly high in the LA, 
see also B. (B) Magnification of boxed area in (A). Nuclei of the amygdala are indicated by 
coloured outlines, (CeL)central nucleus, lateral part, (CeM) central nucleus medial part, (LA) 
lateral amygdala, (BLA) baso-lateral amygdala. (C) Pathways involved in fear conditioning. 
The LA is currently believed to be the only input station of the amygdala for conditioned 
stimuli. It is connected to the CeM via intercalated cells positioned between the BLA and the 
CeM. The CeM is the only significant source of amygdala projections to the brain stem (BS), 
which in turn mediates the behavioral responses of fear, such as startling and freezing. It has 
been shown that chemical or electrical excitation of the CeM elicits the behavioral correlates of 
fear (reviewed in Davis, 2000). Omitted in the scheme are projections from the LA to the BLA, 
which have been shown to be irrelevant for the acquisition of conditioned fear (Amorapanth et 
al., 2000; Holahan and White, 2002; Nader et al., 2001) .The BLA projects to all regions in 
the Central nucleus (CE), not shown. In addition there are projections from the LA to the CeL 
and from the CeL to the CeM, however, the CeL to CeM projections are GABAergic and would 
lead to an inhibition of CeM and therefore would decrease rather than augment fear 
conditioning. There is also direct input in the CeM from the posterior part of the thalamus 
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which likely transmits multimodal sensory information. (Glu) Glutamate.  Adapted from  (Pare 
et al., 2004). 
 
The analysis of knock-out mice has revealed several molecules that are involved in LTP in 
the amygdala, such as Ras-GRF or GRF1, a GEF for Ras whose null mutants show reduced 
amygdala LTP and and impaired memory consolidation in fear conditioning tests (Brambilla 
et al., 1997) or Rin1, a Rab5-GEF (please also refer to chapter 1.2). Rin1-/- mice in contrast 
to Ras-GRF-/- show increased amygdala LTP and enhanced fear memory (Dhaka et al., 
2003). The authors propose the model shown in Figure 13, wherein Ras signalling is vital for 
LTP induction, hence Rin1 acting as a negative modulator would prevent Raf from binding 
to Ras under wt conditions and thereby prevent Ras-Raf-MAPK signalling. This is in 
accordance with Ras-GRF acting as a positive modulator of Ras-signalling and the 
respective LTP phenotypes of Rin1-/- and Ras-GRF-/- mice in the amygdala (Brambilla et al., 
1997; Dhaka et al., 2003). 
 
 
 
Figure 13 Ras signalling modulation by Rin1 and Ras-GRF in amygdala LTP 
(left side) Schematic representation of Ras signalling leading to LTP in the amygdala and its 
modulation by Rin1 and Ras-GRF. Positive interaction/ induction represented by arrows. Rin1 
prevents Raf from binding to Ras, indicated by a red bar. 
(right side) Rin1 KO (knock-out) mice show elevated Ras signalling and increased LTP whereas 
Ras-GRF KO mice display reduced Ras signalling and reduced LTP. Adapted from Dhaka et al, 
2003. 
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1.5 Summary of the thesis project 
 
As outlined in chapter1.2, Rin1 has many interesting properties. It links RTK signalling with 
endocytosis and the Ras-MAPK pathway. Moreover, Rin1 is almost exclusively expressed in 
the postnatal brain and there most prominently in regions important for learning and 
memory, such as the hippocampus and the amygdala. At the start of my thesis work, nothing 
was known about the function of Rin1 in mature neurons which motivated me to investigate 
the role of Rin1 with regard to this aspect. 
First, I attempted to discover novel interactors of Rin1 using a proteomic approach in a 
neuronal cell line, as we were convinced that the list of Rin1-binding proteins known until 
then was far from complete. We succeeded on one hand to purify known interactors of 
Rin1, such as Ras and on the other hand found a number of novel interactors with intriguing 
functions in the nervous system or in cellular processes such as endocytosis. Future 
experiments will be aimed at validating these novel candidates we co-purified with Rin1 
and to uncover the role they play in Rin1-mediated events.  
The expression pattern of Rin1 in the postnatal brain was strikingly similar to a particular 
Eph-receptor, EphA4. This prompted me to further investigate a potential relationship 
between these two molecules. I found Rin1 to be phosphorylated downstream of EphB2 in a 
neuronal cell line and was able to demonstrate physical interaction between EphA4 and 
Rin1 in vitro and in synaptic membranes from adult mouse forebrain by co-
immunoprecipitations. 
Next, I investigated the role of Rin1 in the endocytosis of EphA4 since it was already known 
that Rin1 plays an important role in early endocytic events in its function as a Rab5GEF 
(chapter 1.2). Very little mechanistic insight existed about the internalisation of Eph 
receptors but I was able to show that EphA4 trafficks through endocytic Rab5 compartments 
in cultured cells and primary neurons. Furthermore, overexpression of Rin1 enhanced the 
endocytosis of EphA4, a phenomenon that depended on the presence of the catalytic 
domain of Rin1, as dominant negative mutants of Rin1 blocked the specific, ligand-induced 
internalisation of EphA4. 
Finally, the fact that Rin1-/- mice display an amygdala LTP phenotype, prompted us to 
investigate whether EphA4-/- mice would show a defect in this aspect as well. We could 
demonstrate that contrary to Rin1 null mutants, EphA4 knockouts are defective in amygdala 
LTP. Thus we proposed a model in which reduced endocytosis of EphA4 in amygdala 
neurons of Rin1-/- mice leads to elevated LTP whereas absence of EphA4 on the other hand 
would prevent LTP. 
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2. Results 
2.1 TAP purifications 
 
In an attempt to discover novel interactors of Rin1, the Tandem Affinity Purification (TAP) 
technology was utilized (Rigaut et al., 1999). I generated the Rin1-CtermTAP fusion protein 
which is schematically outlined in Figure 14.  
 
 
Figure 14 Schematic representation of the Rin1-cTAP fusion protein 
The full-length Rin1 protein was C-terminally fused to the TAP-tag consisting of CBP, the TEV 
cleavage site and ProtA. Sizes of proteins/ domains not to scale. (N) N-terminus, (C) C-
terminus, (CBP) Calmodulin-binding protein, (TEV) tobacco etch virus protease cleavage site 
(indicated by a yellow star), (ProtA) ProteinA. 
 
The cTAP-fusion protein was expressed in the human neuroblastoma cell line SK-N-BE2 and 
complexes of Rin1 and interacting proteins were purified from these cells. Purified proteins 
were identified by mass spectrometry by collaborators at Cellzome, Inc. and analyzed with 
available databanks online. 
Rin1 cells were either not treated (NT) prior to the TAP procedure or treated with vanadate 
(V). Vanadate is a general phosphatase inhibitor and leads to hyper-phosphorylation on 
tyrosine residues of cellular proteins since the balance between phosphorylation by kinases 
and de-phosphorylation by phosphatases is skewed. Vanadate treatment was employed to 
ensure the stability of possible interactions between phospho-tyrosine and the Rin1 SH2 
domain. For a picture of the stained SDS gel please see Figure 15. 
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Figure 15 
SDS PAGE of Rin1 Tandem Affinity Purification 
Coomassie-stained SDS gel with TAP samples from 
SK-N-BE2-Rin1CtermTAP cells, either untreated 
(NT) or vanadate-treated (V) and separated by 
electrophoresis. Indicated in red are the gel 
fragments that were cut and subjected to mass 
spectrometry by collaborators at Cellzome, Inc.. 
 
 
 
 
 
Mass spectrometry results were received from Cellzome, Inc. as annotated raw data lists 
indexing proteins by IPI (International Protein Index) accession number. Descriptions of 
protein identity and function were obtained from the EMBL-EBI (European Bioinformatics 
Institute) website by entering the respective IPI number for the protein of interest into the 
databank search field (http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?-page+top) and 
following the link to the UniProtKB/Swiss-Prot databanks if available to obtain more 
detailed information. The list presented in Figure 16 shows all interactors purified from SK-
N-BE2-Rin1-CtermTAP cells except proteins that have been classified as “sticky” by 
Cellzome. These proteins have been identified in virtually all complex purifications 
performed and are therefore most likely unspecific interactors. They have been omitted 
from the table shown here except for 14-3-3 proteins alpha/beta, zeta/delta and epsilon 
since they have previously been shown to be interactors of Rin1 (Han et al., 1997; Wang et 
al., 2002). 
 
Figure 16  
Rin1 interactors identified with Tandem Affinity Purification and Mass Spectrometry 
For Figure legend please refer to page 42. 
 
accession nr. description NT V 
    
IPI00023064.1 UPF0240 protein C6orf66 x - 
IPI00033598.1 14-3-3 protein gamma, YWHAG (psp!) x x 
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IPI00021263.1 14-3-3  protein zeta/delta, YWHAZ (psp!) x x 
IPI00163495.1 14-3-3 protein beta/alpha, YWHAB, Protein kinase C (PKC) 
inhibitor protein-1,  KCIP-1 (cytoplasmic) 
x - 
IPI00000816.1 14-3-3 protein epsilon, YWHAE (psp!) x x 
IPI00030286.1 14-3-3 protein eta, YWHAH (activates tyrosine and tryptophan hydroxylases in 
the presence of CAMKII, strongly activates PKC; potential multifunctional regulator of the 
cell signaling processes mediated by both kinases) 
x x 
IPI00018146.1 14-3-3 protein theta, 14-3-3 protein tau, HS1 protein, YWHAQ 
(cytoplasmic, in neurons, axonally transported to the nerve terminals) 
x x 
IPI00157362.1 40S RIBOSOMAL PROTEIN S10 x - 
IPI00026593.1 60S ribosomal protein x - 
IPI00022891.1 ANT1,  ADP/ATP translocase 1, SLC25A4 (catalyzes the exchange of ADP 
and ATP across the mitochondrial inner membrane) 
x x 
IPI00018198.1 Centrosomal protein of 27 kDa, Cep27 protein  x - 
IPI00027839.1 CRH,  corticoliberin precursor x x 
IPI00018289.1 DNA-DIRECTED RNA POLYMERASE II 23 KDA POLYPEPTIDE x - 
IPI00022018.1 DPM1,  Dolichol-phosphate mannosyltransferase (ER) x - 
IPI00001022.1 FKSG19 (Myofibrillogenesis regulator MR-1), hypothetical protein x - 
IPI00101627.1 GRP75, HSPA9 (stress-70 protein, mitochondrial precursor (75 kDa glucose regulated 
protein) (GRP 75) (Peptide-binding protein 74) (PBP74) (Mortalin) (MOT)) 
x - 
IPI00025512.2 heat-shock protein beta-1 (HspB1) x x 
IPI00155062.1 heterogeneous nuclear ribonucleoprotein H1,  hnRNP H (Part of a 
ternary complex containing FUBP2, PTBP1, PTBP2) 
x - 
IPI00031701.1 hnRNP A1, heterogeneous nuclear ribonucleoprotein A1 - x 
IPI00000006.1 HRas x x 
IPI00010440.4 HS1-BINDING PROTEIN, HAX1, may function in promoting cell survival, may also 
associate with cortactin (endocytosis and golgi, scaffold for actin assembly and 
organisation)/EMS1 in nonlymphoid cells 
x x 
IPI00103303.1 hypothetical protein FLJ22555 x - 
IPI00151354.2 hypothetical protein FLJ37183 x - 
IPI00026593.1 hypothetical protein XP_016822 x - 
IPI00089349.1 hypothetical protein XP_088787 x - 
IPI00031821.1 ITM2b, integral membrane protein 2B,  Transmembrane protein BRI 
(may be associated with familial British dementia (FBD)  characterized by progressive 
dementia, spasticity, and cerebellar ataxia) 
x x 
P01116 KRas2 x x 
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(swissprot) 
IPI00009650.1 LCN1, lipocalin1  x x 
IPI00012369.1 MAD2A, mitotic spindle assembly checkpoint protein (nuclear) x x 
IPI00008868.1 MAP1B,  Microtubule-associated protein 1B ( phosphorylated MAP1B may 
play a role in the cytoskeletal changes that accompany neurite extension) 
x - 
IPI00003968.1 NDUFA9, ( NADH-ubiquinone oxidoreductase 39 kDa subunit, mitochondrial precursor; 
transfer of electrons from NADH to the respiratory chain) 
x x 
IPI00025796.1 NDUFS3 (NADH-ubiquinone oxidoreductase 30 kDa SU, mitochondrial precursor) x x 
IPI00142462.3 no entry x x 
IPI00178653.1 no entry x - 
IPI00180803.1 no entry x - 
IPI00000005.1 NRas x x 
IPI00003174.1 P4HA1, Prolyl 4-hydroxylase alpha-1 subunit precursor (catalyzes the 
posttranslational formation of 4- hydroxyproline in -Xaa-Pro-Gly- sequences in collagens 
and other proteins) 
x - 
IPI00006052.1 PFDN2,  Prefoldin subunit 2 (binds to nascent polypeptide chain and promotes 
folding in an environment with many competing pathways for nonnative proteins) 
x - 
IPI00002567.1 Phosphate carrier protein, mitochondrial precursor (PTP), SLC25A3 
(transport of phosphate groups from the cytosol to the mitochondrial matrix) 
x x 
IPI00022974.1 PIP,  Prolactin-inducible protein precursor (secretory actin-binding protein) - x 
IPI00002412.1 PPT1, PALMITOYL-PROTEIN THIOESTERASE 1 PRECURSOR (removes 
thioester-linked fatty acyl groups such as palmitate from modified cysteine residues in 
proteins or peptides during lysosomal degradation) 
x - 
IPI00144171.1 predicted: similar to 60S ribosomal protein L7 x - 
IPI00085960.1 predicted: similar to immunoglobulin binding protein 1(CD79A-BINDING 
PROTEIN 1, B Cell Signal Transduction molecule alpha 4, ALPHA 4 PROTEIN) 
x - 
IPI00052113.3 predicted: similar to POTE2A, similar to FKSG30 x - 
IPI00032183.1 PRO1472, HSP DnaJ - x 
IPI00028077.1 PSEN1 FAD mutant M146V, presenilin 1, PS1, PS-1, Psnl1 (catalytic 
subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the 
intramembrane cleavage of integral membrane proteins such as Notch receptors and APP 
(beta-amyloid precursor protein), integral membrane protein, Golgi and endoplasmic 
reticulum, bound to Notch also at the cell surface) 
x - 
IPI00016833.1 PSMA2,  proteasome subunit alpha type 2 x - 
IPI00000788.1 PSMA5,  proteasome subunit alpha type 5 x - 
IPI00024175.1 PSMA7, proteasome subunit alpha type 7 x - 
IPI00000814.1 PSMB5,  proteasome subunit beta type x - 
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IPI00023919.4 PSMC5,  26S PROTEASE REGULATORY SUBUNIT 8 - x 
IPI00008527.1 RPLP1,  60S acidic ribosomal protein P1 x - 
IPI00029750.1 RPS24,  40S ribosomal protein S24 x - 
IPI00014458.1 SCO2 protein homolog, mitochondrial precursor ( a copper chaperone, 
transporting copper to the Cu(A) site on the cytochrome c oxidase subunit II (COX2)) 
x - 
IPI00009693.1 SDHA (succinate dehydrogenase [ubiquinone] flavoprotein SU, mitochondrial precursor) x - 
IPI00069475.1 similar to 40S ribosomal protein S18 x - 
IPI00060803.1 similar to discoidin I-gamma x x 
IPI00047765.3 similar to tubulin alpha chain x - 
IPI00029744.1 SSBP1 (single-stranded DNA-binding protein, mitochondrial precursor (Mt-SSB) (MtSSB) 
(PWP1-interacting protein 17)) 
x - 
IPI00017897.2 SSR1,  Splice Isoform 1 of Translocon-associated protein alpha SU 
precursor ( TRAP proteins are part of a complex whose function is to bind calcium to the 
ER membrane and thereby regulate the retention of ER resident proteins) 
x - 
IPI00164305.1 stomatin-like2, SLP-2,  EPB72-like 2 ( peripheral membrane protein and 
associated with the cytoskeleton,  belongs to the band 7/mec-2 family) 
x - 
IPI00012795.1 TRIP-1,  TGF-beta receptor interacting protein 1,  EIF3S2,  (binds to the 
40S ribosome and promotes the binding of methionyl-tRNAi and mRNA,  phosphorylated 
by TGF-beta type II receptor) 
x - 
IPI00027284.2 UQCRC2, Ubiquinol-cytochrome-c reductase complex core protein 
2, mitochondrial precursor 
x - 
IPI00002646.1 UXT protein,  x - 
IPI00004537.2 ZW10 INTERACTOR,  Zwint-1 (nuclear, associated with the kinetochore) x - 
 
Figure 16 
Rin1 interactors identified with Tandem Affinity Purification and Mass Spectrometry 
SK-N-BE2 cells stably expressing TAP-tagged Rin1 were left untreated or treated with 
vanadate prior to harvesting of cells. Lysates were analysed by mass spectrometry, identified 
proteins indexed with IPI accession numbers and further information about expression and 
function was obtained through NCBI databases online. Proteins, previously published to be 
interactors of Rin1 are highlighted in orange, interesting candidates in the nervous system are 
highlighted in green. If proteins are known by several aliases, the most common name is listed 
and alternate names are mentioned additionally. (NT) not treated, (V) vanadate-treated, 
(psp!) potentially sticky protein.   
 
 
Results 
 43 
 
One of the first known interactors of Rin1 to be identified by Colicelli and colleagues was 
Ras (Colicelli et al., 1991; Han and Colicelli, 1995). We found all three Ras isoforms, 
namely  Hras (Harvey rat sarcoma virus oncogene), Kras (Kirsten rat sarcoma viral 
oncogene homolog) and Nras (neuroblastoma ras oncogene) present in our TAP purifications 
in untreated as well as vanadate-treated conditions. In preliminary experiments, we 
confirmed the interaction between Rin1 and Nras (Figure 17). GST-pulldowns were 
performed by Ben Short, PhD using Nras-GST fusion proteins incubated with total forebrain 
lysate from adult mice as a source of Rin1. We found a strong interaction of Rin1 with the 
GTP-bound Nras and a concomitant depletion of Rin1 in the lysate after the pulldown. The 
GDP-bound Nras only precipitated a very small amount of Rin1. Equal amounts of the 
forebrain lysate used as input in the pulldowns were loaded for comparison. Furthermore, 
we transiently expressed Nras-Q61L (GTPase-deficient, GTP bound Nras) and Rin1 in HeLa 
cells and could show co-immunoprecipitations in both directions (data not shown). An 
enhancement of the Rin1 – Ras interaction due to GTP loading of Ras was already shown 
previously (Han and Colicelli, 1995) 
 
Figure 17 Rin1 interacts with Nras in a GST-
pulldown 
 Constitutive active and inactive forms of 
Nras-GST fusion proteins, GTP-Nras and 
GDP-Nras, respectively, were incubated with 
total forebrain lysate from adult wt mice. Equal amounts of the lysates after the pulldowns 
were loaded for comparison and show a depletion of Rin1 in the GTP-Nras sample. U: 
unbound, B: bound, PD: pulldown 
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2.2 Rin1 expression 
 
2.2.1 Generation and validation of Rin1-specific antibodies 
 
To study Rin1 in neurons and intact brain tissue, we considered the generation of antibodies 
against mouse Rin1 to be of high priority since the only commercially available antibody 
was directed against human Rin1 and failed to recognize the murine homologue. I cloned a 
C-terminally (His)6-tagged expression construct, confirmed induction of protein expression 
and the functionality of the (His)6-tag. Rodrigo Sanchez in our laboratory performed the 
large scale antigen purification from bacterial lysates and prepared the serum obtained 
from the immunised animals. Immunisation of two rabbits (#1203 and #1204) and one 
goat (#113) were carried out by the in-house facility of the MPI for Biochemistry/ 
Neurobiology. The  antibody from rabbit #1203 yielded the best results hence data shown 
in this study was obtained with this serum. 
To confirm specificity of the polyclonal rabbit anti-Rin1 antibody generated in our 
laboratory, control experiments were performed. As can be seen in Figure 18, panel A, 
HeLa cells transiently transfected with Rin1-FL (full-length protein) show a strong 
cytoplasmic staining when stained with anti-Rin1 as revealed by anti-rabbit*Cy2. A nuclear 
stain (HOECHST) marks all cells in the field. In the merged images, the presence of 
additional, untransfected cells can be seen that do not show any Rin1 signal. 
 
Figure 18  
Polyclonal anti-Rin1 
antibody detects 
overexpressed Rin1 
HeLa cells were 
transiently transfected with Rin1-FL and stained for Rin1 (dilution 1:500) in green (A, C). A 
nuclear stain shows all cells present in the selected field in blue (B, C). Untransfected cells show 
no staining. Scale bar represents 50μm. 
 
Western blots performed with lysates from wild type adult mouse forebrain show a strong 
band at approximately 90kDa, which appears weaker in Rin1 heterozygous mice and is 
completely absent in Rin1 k.o. animals which were kindly provided by the Collicelli 
laboratory (Figure 19). 
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Figure 19 Rin1 expression in adult 
mouse forebrain  
Total lysates from adult mouse 
forebrains, either Rin1wt/ wt (lanes 
1, 2, 7), Rin1+/- (lanes 3, 6), or 
Rin1-/- (lanes 4 and 5) were 
immunoblotted against Rin1. Anti-Tubulin antibody was used as loading control (α Tub), 50μg 
protein per lane. 
 
Next, the antibody was used on wild type forebrain (cortex and hippocampus) or 
hippocampal neurons dissected from E18.5 embryos and plated on poly-lysine/laminin 
coated glass coverslips. Neurons were cultured for different lengths of time (9 days in vitro 
(DIV), 13 DIV) to monitor Rin1 expression since Rin1 protein was undetectable by western 
blot at E18.5 (Figure 23). Immunofluorescence stainings were performed using 
aforementioned rabbit polyclonal Rin1 antibody (#1203) and pre-immunisation serum of 
the same rabbit at the same dilution as a control (see Figure 20). Images were acquired 
with equal exposure times to compare staining results. Already at 9 DIV there is a clear 
difference between the pre-immune serum and the anti-Rin1 antibody staining and Rin1 
positive puncta could be observed along neurites in addition to a strong cytoplasmic 
staining. 
 
Figure 20 Immunofluorescence staining of cultured forebrain neurons 
Mouse forebrain neurons were cultured for 9 DIV (A-D) or 13 DIV (E-H) and stained with a 
1:100 (9 DIV) or 1:500 dilution (13 DIV) of either pre-immune serum (A, E) or anti-Rin1 
polyclonal antibody (B, F). Higher magnification of boxed areas in A, B, E, F can be seen in C, 
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D, G and H, respectively. Pictures were acquired with exposure times of 0.5sec (A-D) or 2sec 
(E-H). Scale bars represent 50μm (A, B, E, F) and 10μm (C, D, G, H). 
 
Pre-immune serum and Rin1 antibody were furthermore applied to coronal sections to 
localise endogenous Rin1 protein in the adult brain. As can be seen in Figure 21, pre-
immune serum showed no detectable staining in CA1 neurons. In contrast, Rin1 antibody 
showed high levels of Rin1 in cell bodies and dendrites. 
Figure 21 Rin1 expression in CA1 neurons 
(A) preimmune serum used as control. (B) Staining with anti-Rin1 antibody, both samples 
processed identically, dilution 1:500, magnification 40x, scale bar 100μm. 
 
 
2.2.2 Rin1 expression in primary neurons 
 
In order to address a potential synaptic localisation of Rin1 protein, co-stainings with anti-
Synaptophysin and anti-PSD-95 were performed on dissociated cultured hippocampal 
neurons. Synaptophysin is a 38 kDa transmembrane protein associated with synaptic 
vesicles often used as a presynaptic marker. PSD-95 (SAP90, Synapse-associated protein 
90) is a 95 kDA multi-PDZ domain scaffold molecule associated with the post-synaptic 
density (PSD) and used as a post-synaptic marker. Rin1 protein, abundantly present in 
dendritic shafts, can also be found in dendritic protrusions and co-localises partly with PSD-
95. Co-staining with PSD-95 was observed as early as 9 DIV (Figure 22, panels A-F) yet 
PSD-95 immunoreactivity remained relatively faint and clusters observed were much 
smaller than at later culture time points (data not shown). A more pronounced punctuated 
pattern of Rin1 localisation could be found along the processes of older neurons in culture 
(21 DIV) in addition to the strong cytoplasmic signal. Especially clusters of strong Rin1 
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immunoreactivity showed a striking co-staining with Synaptophysin (see Figure 22, panels 
G-L). 
 
Figure 22 Rin1 protein localisation in cultured hippocampal neurons 
Hippocampal neurons (E18.5) were cultured for 9 DIV and stained for Rin1 (green) and PSD-
95 (red) (A-F), or 21 DIV and stained for Rin1 (green) and Synaptophysin (red), (G-L). D-F 
are magnifications of pictures shown in A-C, J-L are magnifications of pictures shown in G-I. 
Arrows indicate examples of co-localisation of the two respective proteins.  Scale bars 
represent 50μm (A to C and G-I), and 10μm (D-F and J-L). 
 
 
2.2.3 Rin1 expression in vivo 
 
It has been previously published that rin1 mRNA is undetectable in embryonic brain, 
expressed at extremely low levels at P0 and is still weak at P6 (Dhaka et al., 2003). These 
findings were supported by a developmental expression profile I did by Western blot 
(Figure 23). Forebrain lysates of mice ranging in age from E13.5 (lysate from whole head) 
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to adult showed no Rin1 expression before P6. Rin1 knock-out forebrain lysate revealed no 
signal at the expected size (97kDa). EphA4 expression increases only slightly during 
development whereas the presynaptic marker Synaptophysin is virtually undetectable 
before E13.5 but shows a marked increase in expression over time paralleling the 
establishment of synapses. 
Figure 23 Developmental 
expression profile of Rin1 
Mouse forebrain protein samples 
(E13.5 –P48) were subjected to 
immunoblotting with the 
antibodies indicated  
 
I used immunhistochemistry with anti-Rin1 antibody and in-situ hybridisation to further 
characterise the expression pattern of Rin1 in the adult brain. Coronal sections of adult 
mouse brain were stained with anti-Rin1 antibody or subjected to in-situ hybridisation with 
rin1 antisense probe. As can be seen in Figure 24, panel A, most Rin1-immunoreactive 
neurons in the cortex were found in layers II-III and layerV; weaker staining could be also 
observed in other layers. Panel B shows individual neurons at a high magnification, taken 
from the same section as shown in A. Panels C and D show localisation of Rin1 protein and 
mRNA, respectively, in the hippocampus. We observed that Rin1 not only localises to cell 
bodies but also to the apical and basal dendrites, especially in the CA1 region of the 
hippocampus (see Figure 24, C).  
 
Figure 24 Localisation of Rin1protein (A-C) and mRNA (D) in the adult mouse brain 
Coronal sections of adult mouse brain, stained with anti Rin1-antibody (A-C) or subjected to 
in-situ hybridisation (D) with rin1 antisense probe. Scale bars 100µm in A, C, E, 10µm in B. 
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I further set out to determine the specific sublocalisation of Rin1 in neurons in vivo, in 
particular whether Rin1 is present at synapses as suggested by the stainings performed on 
cultured hippocampal neurons (Figure 22). To address this question, immunofluorescence 
stainings were performed on adult brain tissue. For technical reasons, the antibody against 
PSD-95 could not be used for stainings on tissue sections. Stacks of confocal images were 
acquired and analysed for localisation of Rin1-positive puncta with regard to the 
localisation of Synaptophysin-positive puncta. Visual examination of these stainings showed 
a remarkable degree of Synaptophysin-Rin1 juxtaposition indicative of an at least partly, 
postsynaptic localisation of Rin1. Therefore, a quantitative analysis was performed in such a 
way that all Synaptophysin positive puncta in single optical sections were marked with a 
mask of circles around the spots of staining and counted. Then this mask was overlaid on the 
merged double staining of both Rin1 and Synaptophysin and the number of circles that also 
encompassed a juxtaposed Rin1-positive spot was counted.  The average number of 
Synaptophysin-positive puncta in a 512 by 512 pixel quadrant at 63x magnification was 
340, a mean of 133  had a juxtaposed Rin1-immunoreactive spot, which corresponds to 
39%. For pictures of the staining and the quantitative analysis, please see Figure 25. 
 
Figure 25 Synaptic localisation of Rin1 
Rin1 staining in red, Synaptophysin staining in green. (A) Rin1 localisation at synapses in the 
CA1 region of the hippocampus. Insets show boxed areas in the single and merged channels at 
high magnification. Images were acquired at 63x magnification with a confocal microscope. 
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Scale bar 50μm. (B) High magnification of a single synaptophysin punctum (left panel, red) 
and Rin1 punctum (middle panel, green) and the merged image suggesting a synaptic 
structure. The close juxtaposition of the two puncta is indicative of a partly post-synaptic 
localisation of Rin1. (C) Average number of puncta counted in 512 by 512 pixel fields of  
single optical confocal planes  at 63x magnification. Error bars represent STDEV. On average, 
133 of the mean total 340 Synaptophysin puncta had juxtaposed Rin1 puncta (t-test, 1 tailed, 
2 sample equal variance: 0,0005) corresponding to 39%. 
 
 
2.2.3.1 Rin1 and EphA4 – a comparison of expression patterns 
 
When investigating Rin1 distribution in the adult brain, I found striking similarities in the 
pattern when comparing it to the expression of Eph-receptors, in particular EphA4. I used 
in-situ hybridisation on coronal slices of adult mouse brain for the comparison. In the 
hippocampus, both messages were expressed at high levels throughout all regions, namely 
CA1-CA3 and dentate gyrus (see Figure 26, B and F). In cingulate cortical neurons their 
expression patterns were nearly indistinguishable (see Figure 26, C and G). In contrast to 
the findings of Dhaka et al., I detected a strong signal of rin1 mRNA in the thalamus, 
distributed in a “salt-and-pepper” fashion strongly reminiscent of ephA4 (see Figure 26, D 
and H). In the amygdala I could observe differences, since ephA4 message was most 
pronounced in the lateral nucleus (LA) and weak in the basolateral nucleus (BLA) whereas 
rin1 was detected at more equal levels throughout these nuclei and also detectable in other 
regions of the amygdala (see Figure 26, A and E and for a scheme of amygdaloid nuclei, 
please refer to chapter 1.4, Figure 12).  
The similarity of expression patterns of rin1 and epha4 were intriguing and prompted me 
to further investigate the possible functions of Rin1 in postnatal neurons, possibly 
downstream of Epha4 signalling. 
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Figure 26 Comparison of rin1 and ephA4 expression in the adult mouse brain 
Coronal sections of adult mouse brain were subjected to in-situ hybridisation with rin1 and 
ephA4 antisense riboprobes. Scale bars equal 500μm in A, B, E and F and 100μm in C, D, G 
and H. Orientation indicated by crosses. (L) lateral, (D) dorsal, (M) medial, (V) ventral. 
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2.3 Tyrosine phosphorylation of Rin1 
 
Rin1 was previously shown in non-neuronal and immortalised cells to facilitate transforming 
growth mediated by BCR/Abl, a process which depended on Rin1 tyrosine-phosphorylation. 
I therefore asked, if Rin1 could be tyrosine phosphorylated in neuronal cell types in 
response to neurotrophic factors. As a model system, I employed the human neuroblastoma 
cell line SK-N-BE2 (for reference see www.atcc.org). I determined the expression of the 
receptors TrkAand TrkB for nerve growth factor (NGF), Brain-derived neurotrophic factor 
(BDNF), respectively and the receptor cMet for hepatocyte growth factor (HGF). As can be 
seen in Figure 27, SK-N-BE2 were tested by Western blot for TrkA and TrkB, which both 
show moderate expression levels. In addition, high levels of cMet, as well as the human Rin1 
were detected. 
 
Figure 27 Human neuroblastoma cell line SK-N-BE2 
Total protein lysates (50μg/lane) of SK-N-BE2 were immunoblotted against the indicated 
proteins and found to be expressing cMet, TrkA, TrkB and Rin1. 
 
Starved cells were stimulated with the respective ligands for these RTKs and tyrosine 
phosphorylation of Rin1 analysed along with MAPK activation to address the different 
kinetics of pathway activation downstream of the different receptors. The time course of 
Rin1 phosphorylation downstream TrkA and TrkB after stimulation with NGF and BDNF, 
respectively, can be seen in Figure 28.  
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Figure 28 Rin1 tyrosine 
phosphorylation downstream 
NGF and BDNF in SK-N-BE2 
SK-N-BE2 were starved for 
24h in 0.5% serum, then 
stimulated with either (A) NGF 
or (B) BDNF. IP α-Rin1 from 
1mg, total lysates (TCL) 50μg 
per lane. Immunoblots against 
the indicated proteins. Time 
course in minutes. 
 
 
 
Rin1 showed a high induction of phosphorylation in response to NGF at the 5 minute time 
point, in total remained high for 30 minutes and showed a decline back to baseline levels 
at the 60 minute time point. In SK-N-BE2, MAPK was phosphorylated robustly but very 
transiently from 5 to 10 minutes after NGF stimulation and decreased to a baseline level 
after 15 minutes. Rin1 phosphorylation downstream TrkB happened with different kinetics 
and was comparatively low. A slight elevation of tyrosine phosphorylation of Rin1 could be 
observed at the two minute time point, and again at 15min but decreased shortly 
thereafter. In contrast to the NGF stimulation, Rin1 phosphorylation seemed delayed when 
compared to MAPK activation, which occured transiently between the 5- and 15 minute 
intervals (Figure 28). 
 
A very different time course was found downstream HGF and its receptor cMet. As can be 
seen in Figure 29, the onset of Rin1 tyrosine phosphorylation was very rapid (1 minute time 
point) and maintained for 15 minutes. The kinetics of MAPK activation paralleled that 
during NGF stimulation.  
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Figure 29 Rin1 phospho-
rylation downstream cMet 
SK-N-BE2 were starved for 
24h and stimulated with HGF 
(time course in minutes) 
Immunoblot against proteins as 
indicated 
 
Next, I investigated whether Rin1 becomes tyrosine phosphorylated downstream Eph 
receptors. Since I wanted to address this question in a system where both the Eph receptor 
and Rin1 were endogenously expressed I had to resort to looking at another receptor than 
EphA4. No suitable in vitro system could be found where EphA4 and Rin1 were both 
expressed and it is known that overexpression of Eph receptors leads to their constitutive 
activation. SK-N-BE2 strongly express Rin1 (Figure 27) but no EphA4 (data not shown), as 
assessed both by immunofluorescence staining and Western blot. Therefore we checked for 
expression of related Eph receptors and found strong levels of EphB2 receptor present in 
these cells. Results obtained with EphB2 may be of particular interest since this receptor 
responds to the same group of ligands as EphA4, namely ephrinB2 and B3. I observed a 
strong but transient phosphorylation of Rin1 on tyrosine residues upon treatment of the cells 
with pre-clustered ephrinB2. The level of this phosphorylation is similar to that after serum 
stimulation for 5 minutes, used here as a positive control. Control samples mock-stimulated 
with pre-clustered Fc show only residual background phosphorylation, present even after 
starvation of the cells (Figure 30, see also Figure 28, panels A and B and Figure 29). These 
results suggest that Rin1 can be tyrosine phosphorylated in neuronal cell types and may be 
a direct substrate of Eph receptors. 
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Figure 30 Rin1 tyrosine phosphorylation downstream EphB2 receptor 
SK-N-BE2 cells were starved for 24h, then stimulated with either pre-clustered Fc alone 
(control) or ephrinB2-Fc. Immuno-precipitations and –blots against proteins indicated. IPs from 
1mg protein, total lysates 50μg per lane. 
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2.4 Rin1 interacts with the EphA4 receptor 
 
To determine whether Rin1 and EphA4 Receptor can physically interact in mammalian cells, 
both proteins were transiently transfected into HeLa cells and co-immunoprecipitations (co-
IPs) were performed. Full length Rin1 can be detected in an anti-EphA4 Receptor 
immunoprecipitation (IP) as shown in Figure 31, A and B whereas controls of receptor-only 
or Rin1-only samples showed no signal after IP when probed for Rin1. We hypothesised a 
SH2 domain dependent interaction between Rin1 and EphA4 and therefore created a point 
mutation in Rin1 (R93E). The arginine at position 93 is part of the highly conserved FLVR 
motif in SH2 domains and has been shown to be the critical residue to make direct contact 
with a phosphorylated tyrosine. The mutation to a glutamic acid should abrogate the 
interaction (Marengere and Pawson, 1992). However, the Rin1-R93E mutant protein co-
immunoprecipitated with EphA4 just as well as the wt full length protein (Figure 31, A). In 
order to confirm that the Rin1 SH2 domain is indeed dispensable for the interaction with the 
Eph receptor, we tested a Rin1 protein lacking the first 169aa including the SH2 domain 
(Rin1ΔSH2) in the same assay. As shown in Figure 31, panel B, the Rin1ΔSH2 mutant protein 
was readily detected in EphA4 IPs at comparable levels to the wt full length Rin1 indicating 
that the SH2 domain of Rin1 is unnecessary for the interaction with EphA4.  
 
 
Figure 31 Co-immunoprecipitation of EphA4 and Rin1 
(A) Rin1-wt or Rin1-R93E and (B) Rin1-wt or Rin1-ΔSH2 were expressed in HeLa cells 
together with EphA4. Immunoprecipitations (IP) and immunoblots against proteins indicated. 
Toyal lysates (TCL) 50 μg per lane, IP from (A) 1mg, (B) 200μg total protein. For a 
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schematic representation of expression constructs used, please refer to Material and Methods, 
chapter 4.1.3, Figure 45. 
 
Next, I tested whether I could also observe this interaction in vivo. I tried to co-IP EphA4 and 
Rin1 from total forebrain lysates of wt adult mice but failed to do so (data not shown). In 
order to increase the probability of detecting the interaction I prepared synaptosome 
fractions from adult forebrain. As shown in Figure 32, Rin1 was only slightly enriched in 
synaptosome fractions when compared to non-synaptosome fractions, whereas PSD95, used 
as a control for fraction purity was almost exlusively detected in the synaptosome sample.  
 
Figure 32 Rin1 is present in synaptosome 
preparations from adult mouse forebrain 
Lanes 1, 3, 5 and 7: 25μg total protein, lanes 
2, 4, 6 and 8: 50μg total protein. Syn: synaptosome fraction, non-syn: non-synaptic fraction. 
Lanes 1, 2, 7, 8 immunoblotted against PSD-95, lanes 3, 4, 5, and 6 immunoblotted against 
Rin1 
 
I furthermore prepared post-synaptic-density (PSD) fractionations and found Rin1 to be 
present in PSD fractions, as shown in Figure 33. The distribution of EphA4 Receptor in non-
synaptosomal and PSD fractions has previously been determined. EphA4 was shown to be 
present in all fractions at comparable levels (Grunwald et al., 2004). 
 
Figure 33 Rin1 is present in PSD fractions prepared 
from adult mouse forebrain 
Total forebrain lysate (10μg), non-PSD and PSD 
fractions (30μg each) were immunoblotted for the 
indicated proteins. Syn (Synaptophysin) and PSD-
95 are shown as markers of fraction purity. As 
expected, Synaptophysin is undetectable in PSD 
fractions, whereas PSD-95 is highly enriched there 
but hardly detectable in total forebrain lysate. 
 
I immunoprecipitated EphA4 from synaptosomal and non-synaptosomal material prepared 
from adult mouse forebrain and tested these samples for the presence of Rin1. I found Rin1 
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to co-immunoprecipitate from the synaptic membrane material but not from a total brain 
lysate nor the non-synaptosomal fraction (Figure 34), indicative of a specific interaction of 
the two proteins at synaptic membranes in the adult brain.  
 
Figure 34 Rin1 interacts with EphA4 in 
synaptosome fractions  
Rin1 was specifically co-immuno-
precipitated with EphA4 from synaptic 
membranes prepared from adult mouse 
forebrains. IPs of  comparable amounts of 
EphA4 from non-synaptosomal fractions 
did not reveal the presence of Rin1. TCL: 
total cell lysate 
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2.5 Internalised EphA4 trafficks through Rab5 compartments 
 
Since it has been published that Rin1 is a GEF for the small GTPase Rab5 (Tall et al., 
2001), which is involved in the early steps of endocytosis (please refer to chapter 1.3 for 
more information on endocytosis, endosomes and Rab5), we sought to establish whether 
internalised EphA4 reaches Rab5 endosomes. It has been shown previously that Eph 
receptors get internalised upon stimulation with soluble pre-clustered ephrin-Fc fusion 
proteins (Zimmer et al., 2003). The route of endocytosis taken by internalised Ephs and the 
regulation of this event however, are unknown. As described in chapter 1.3, Figure 8, there 
are many different pathways that internalised molecules take inside the cell, some of which 
converge on Rab5-positive endosomes, others that do not. Since several experts on Rab5 
agree that stainings for the endogenous molecule cannot be achieved (Marino Zerial, 
Martha Miaczynska personal communication), I used a constitutively active Rab5-GFP (GFP-
Rab5Q79L) fusion protein which allows visualisation of enlarged early endosomes. I 
transfected HeLa-EphA4 (for details on this line stably expressing EphA4, please see 
chapter 2.6 and Figure 38) with GFP-Rab5Q79L and found EphA4 to accumulate in Rab5 
positive endosomes (Figure 35) after stimulation with ephrinB3-Fc (for details about pre- 
and post-permeabilisation staining, please refer to the methods section and see chapter 2.6 
and Figure 39). Stimulation with Fc alone did not induce endocytosis and no Eph-ephrin 
complexes were found in Rab5 endosomes (data not shown). To verify that expression of 
the Rab5 construct did not affect the size of receptor-ligand clusters per se, I performed 
controls using a GFP-tagged wt Rab5 construct or transfecting only GFP, which gave 
comparable results (data not shown).  
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Figure 35 Internalised EphA4 reaches Rab5 compartments in stable HeLa-EphA4 cells 
HeLa cells stably expressing EphA4 were transfected with Rab5Q79L and stimulated with pre-
clustered ephrinB3-Fc for 30 min. Cells were stained for surface receptor-ligand-complexes 
with an anti-Fc antibody conjugated to Cy5 (false colour blue in the merged images) and total 
receptor-ligand-complexes with an anti-Fc antibody conjugated to TexasRed (false colour red). 
In the merged images, surface receptor clusters appear in purple, indicated by arrowheads. 
Internalised clusters are stained in red and complexes that have reached Rab5-positive 
endosomes appear orange, indicated by arrows. Scale bar (A) 50μm 
 
 
I was interested to see whether endogenous EphA4 would behave the same way. To 
address this question I used primary cultured hippocampal neurons as a model and could 
show that they express high levels of EphA4 in the first week in culture. Furthermore I 
confirmed that when stimulated with ephrinB3-Fc and subsequently stained against Fc and 
with a specific antibody against EphA4, virtually all clusters detected with the anti-Fc 
antibody were also positive for EphA4 (data not shown, see also (Egea et al., 2005)). Thus I 
proceeded to use only the anti-Fc staining to follow clustered EphA4, which in addition only 
visualises receptor molecules engaged by the ligand. As can be seen in Figure 36, 30 
minutes after addition of preclustered ephrinB3-Fc, clustered receptor can be detected on 
the surface of neurons as well as inside the processes and the soma (panels A, B and 
magnifications in E and F). Large clusters of internalised receptor ligand complexes co-
localised with Rab5 positive endosomes (panels D and H, indicated by arrows). Similar 
results were observed in glia cells also present in the culture (see panels I to P). Thus I 
concluded that EphA4 trafficks through Rab5 endosomes after ligand-induced endocytosis. 
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Figure 36 Internalised EphA4 reaches Rab5 positive endosomes in primary cultures 
Hippocampal neurons were transfected with GFP-Rab5Q79L at 2 DIV and cultured for an 
additional 48h before stimulation with pre-clustered ephrinB3-Fc for 30 min. Cells were stained 
for surface receptor-ligand-complexes with an anti-Fc antibody conjugated to Cy5 (false 
colour blue) and total receptor-ligand-complexes with an anti-Fc antibody conjugated to 
TexasRed (false colour red). Examples show a transfected neuron (A-D and magnifications in 
E-H) and a transfected glia cell (I-L and magnifications in M-P). In the merged images, surface 
receptor clusters appear in purple, internalised clusters in red and complexes that have reached 
Rab5-positive endosomes appear yellow or orange, indicated by arrows. Scale bars in A-D 
and I-L 10µm, E-H and M-P 5 µm.  
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2.6 Rin1 enhances the internalisation of EphA4 
 
Next, I asked if and how Rin1 interferes with the internalisation of EphA4-receptor. I 
addressed this question in two different experimental setups. First a biochemical approach 
was taken using surface biotinylation assays. For a brief description of experimental 
procedures, please see legend in Figure 37, for details, please refer to the methods section. 
In control samples (eGFP transfected), a clear increase of internalisation could be observed 
over the time course of stimulation with pre-clustered ephrinB3Fc when compared to the 
stimulation control with pre-clustered Fc alone. Samples in which Rin1-FL was expressed 
show a marked increase of internalisation when compared with control samples (eGFP). 
Already at 20 minutes of ephrinB3-Fc stimulation, the amount of endocytosed EphA4 was 
markedly enhanced, a trend which was even more dramatic at the 60 minute time point 
(Figure 37). 
 
Figure 37  
Rin1 enhances 
internalisation of EphA4  
HeLa cells stably 
expressing EphA4 
Receptor were trans-fected 
with eGFP as a control or 
Rin1-FL and subjected to a 
surface biotinylation assay. 
Surface molecules were 
biotinylated and then internalisation initiated by stimulation with ligands, pre-clustered Fc 
(control) or ephrinB3-Fc. After indicated timepoints, cells were placed on ice and biotin was 
stripped from remaining surface molecules. Avidin pulldown (PD) is a readout for internalised 
proteins. Total amount of protein present is shown in total cell lysates (TCL), Immunoblots 
against indicated proteins. (b3) ephrinB3-Fc. 
 
In a second approach, a pre- and post-permeabilisation staining procedure on the stable 
Hela-EphA4 cells was employed to quantify the number of internalised EphA4-receptor 
clusters. Native HeLa cells did not show surface clusters when stimulated with ephrinB3-Fc, 
thus all receptor molecules identified in the staining were indicative of EphA4. Since the 
population of generated HeLa-EphA4 were heterogeneous in their expression levels even 
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though originating from a single cell clone, there were cells with no detectable receptor 
expression when stained with anti-Fc antibody after stimulation (see Figure 38, panel B).  
It has been established before that stimulation with clustered Fc alone does not lead to any 
detectable staining since there is no binding of Fc alone to any surface molecules (see 
Figure 38, panel A).  
 
Figure 38 
HeLa cells stably 
expressing EphA4 
receptor 
Stable HeLa-EphA4 cells 
were stimulated for 40 
min with either pre-
clustered Fc (control, panel A) or ephrinB3-Fc. (B) and stained with TR-conjugated anti-Fc 
antibody. Note that there are many cells with undetectable levels of receptor expression in the 
population of this stable clone (B: faint shadows of EphA4 negative cells around the cells with 
clear receptor clusters). Scale bar 50μm 
 
In Figure 39, an example of surface and total anti-Fc staining is shown. Clusters shown in 
red in the merged image (panel C and blowup in F) are indicative of internalised receptor-
ligand complexes.  
 
Figure 39 Pre-post-permeabilisation staining for Eph-ephrin complexes 
HeLa cells stably expressing EphA4 were stimulated for 30min with pre-clustered ephrinB3-Fc. 
Shown are EphA4-ephrinB3 complexes identified on the surface of the cells (pre-
permeabilisation staining in A, D, green or yellow clusters in merged image C and F) and total 
number of complexes (post-permeabilisation staining in B, E). Internalised clusters appear red 
in the merged image. Scale bars 50μm in A-C and 10μm in D-F. 
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The number of internal receptor-ligand clusters counted after permeabilisation of the cells 
was divided by the total number of clusters thus resulting in a percentage of EphA4-
receptor internalisation for each individual cell analysed. Cells transfected with eGFP show 
an average internalisation rate of 19%, cells transfected with Rin1 show a highly significant 
increase of internalisation to 29% (Figure 40).  
 
Figure 40 Enhancement of EphA4 
internalisation in the presence of Rin1 
HeLa stably expressing EphA4 were 
transfected with either eGFP (control) or 
Rin1 and eGFP (ratio 5:1) By pre- and 
post-permeabilisation staining for 
receptor-ligand complexes and 
calculation of ratio of internalisation, an 
increase in the amount of internalised receptor from 19% in control samples to 29% in Rin1 
transfected samples was observed. Error bars represent standard deviations. T-test (2-tailed, 
equal variance) 1,28E-12 
 
We next examined whether the positive effect of Rin1 expression on the internalisation of 
EphA4 is due to Rin1 guanine nucleotide exchange factor (GEF) activity. It has been 
described previously that Rin1 includes a Vps9p-like GEF domain in the C-terminal half of 
the protein with which it acts as an exchange factor for the small GTPase Rab5 (Tall et al., 
2001). We designed two putative dominant negative constructs, in which either the entire 
GEF domain was deleted or only the first 48aa, termed Rin1-ΔGEF and Rin1-splice, 
respectively. Rin1-splice corresponds in sequence to a naturally occurring splice variant of 
Rin1 (Han et al., 1997) that has been shown to be unable to stimulate GDP release from 
Rab5 (Tall et al., 2001). As shown in Figure 41, there was a moderate increase in EphA4 
internalisation after 60min stimulation with ephrinB3 when compared to Fc control in the 
eGFP and an enhanced endocytosis in the Rin1-FL transfected samples. Rin1-ΔGEF and 
Rin1-splice only showed internalisation levels comparable to the Fc-stimulated eGFP sample 
but no induction of endocytosis after specific stimulation with pre-clustered ephrinB3. This 
indicates that the specific increase observed in Rin1-FL-transfected samples was due to the 
catalytic activity of Rin1 and that remaining, low-level endocytosis of EphA4 still seen with 
∗∗∗ 
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the Rin1 dominant negative constructs and in Fc-stimulated samples is a residual, ligand-
independent form of internalisation. 
 
Figure 41 GEF-deficient Rin1 blocks 
EphA4 internalisation induced by 
stimulation with ephrinB3 
HeLa cells stably expressing EphA4 
were transiently transfected with 
eGFP (control), Rin1-FL, Rin1-ΔGEF 
or Rin1-splice, stimulated for 60min 
with either Fc alone or ephrinB3-Fc 
and subjected to a surface 
biotinylation assay. Avidin Pulldown 
(PD) is a readout of internalised proteins. Arrows indicate from top to bottom Rin1-FL, Rin1-
splice and Rin1-ΔGEF, lower bands are most likely degradation products of the overexpressed 
proteins. TCL: total cell lysate. 
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2.7 EphA4-/- mice have a LTP defect in the amygdala 
 
The relationship between Rin1 and EphA4 I have established so far involves physical (albeit 
possibly indirect) interaction of the two molecules, an induction of tyrosine phosphorylation 
in Rin1 downstream Eph receptors and a necessary and sufficient role for Rin1 in the 
endocytosis of EphA4. Therefore I was interested to see whether EphA4 mutant mice had 
any defects in amygdala LTP, since Rin1 knockouts have been shown to have elevated 
amygdala LTP (Dhaka et al., 2003). To see the expression pattern of Rin1 and EphA4 in 
amygdala, please refer to Figure 26. Coronal slices were sectioned at the level where the 
external capsule is visible encompassing the lateral (LA) and basolateral (BLA) nuclei of the 
amygdala (for an example and a schematic overview of amygdaloid nuclei, please refer 
to chapter 1.4, Figure 12).   
Slices were stimulated using a high frequency stimulus (HFS, 2sec 50Hz), placing the 
stimulating electrode in the external capsule and the recording electrode in the LA (Figure 
42, panel A). EphA4-/- (n=21 slices from 9 animals) and EphA4wt/wt (n=17 slices from 7 
animals) control littermates were subjected to this protocol. When compared to wt 
littermates, EphA4 null mice show an initial (first ten min after HFS), weak rise in the 
normalised field potential (FP) amplitude but then fail to display LTP induction (Figure 42, 
panel B). Electrophysiological recordings were performed by Dr. Matthias Eder, MPI for 
Psychiatry, Munich. 
 
Figure 42 
EphA4-/- mice are defective in amygdala LTP 
(A) Schematic view of the 400μm coronal slices 
used for the LTP experiments. Location of the 
stimulation (Stim) and recording (Rec) electrodes 
are indicated. (LA) lateral amygdala, (BLA) basolateral amygdala. (B) EphA4 knockout mice 
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(ko, black circles, n=21 slices from 9 animals, 2-3 slices per animal) fail to display long term 
potentiation (LTP) after high frequency stimulation (HFS), EphA4wt/wt littermates (wt, open 
circles, n=17 slices, 2-3 slices per animal) are shown as control. Paired student´s t-test: b vs. a, 
p= 0.038 c vs. a, p= 0.73; unpaired student´s t-test: b vs. c, p= 0.018. Experiments 
performed by Dr. Matthias Eder, MPI for Psychiatry, Munich. 
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3. Discussion 
 
3.1 Rin1 interactors identified by TAP 
 
The tandem affinity purification (TAP) technology (Gavin et al., 2002; Rigaut et al., 1999) 
has emerged as a useful tool to purify whole complexes of interacting proteins from cells or 
transgenic organisms. The general picture of protein-protein interaction and their 
importance for intracellular events has changed since it has become clear that most likely, 
proteins are engaged not only with one or two binding partners but instead take part in 
large signalling complexes. These may vary in their composition depending on cellular 
context or the combination of signals received by the cell. Hence a method was in demand 
that would allow retrieval of such multimeric complexes from cells or ideally from transgenic 
animals, which would identify interactors from a more physiological context. TAP is ideally 
suited for such an endeavour. We employed the TAP technology in this study to obtain more 
information about proteins that interact with our protein of interest, Rin1. We designed a 
TAP-tagged Rin1 construct as the bait (Figure 14) which was integrated into the SK-N-BE2 
human neuroblastoma cell line by retroviral infection. We chose a neuroblastoma cell line 
since Rin1 shows strong expression in the nervous system and we anticipated the presence 
of at least some neuron-specific interactors in the SK-N-BE2 line. The purification of 
complexes was performed twice, once in untreated conditions and once in the presence of 
vanadate, a tyrosine-phosphatase inhibitor to ensure phospho-tyrosine dependent 
interactions. In collaboration with cellzome, the company which performed the mass-
spectrometry analysis of the purified proteins, we were able to identify a list of proteins 
which was further annotated with information obtained from bioinformatical databanks 
online (NCBI, UniProtKB/Swiss-Prot and see Figure 16). Among the proteins identified are 
published interactors of Rin1, such as H-Ras and 14-3-3 proteins (Han and Colicelli, 1995; 
Han et al., 1997) strengthening the relevance of molecules identified with this technology. 
K-Ras and N-Ras, two other members of the Ras family of GTPases were also discovered 
and in a preliminary experiment (GST-pulldown) we confirmed that N-Ras is able to 
precipitate Rin1 from adult mouse forebrain (Figure 17). Recent evidence points to diverse 
roles of different Ras isoforms at different subcellular locations (Hancock, 2003; Rocks et 
al., 2006; Silvius, 2002). N-ras for example has been shown to localise to the Trans-Golgi-
Network (TGN) where it potently activates the MAPK-pathway (Chiu et al., 2002; Goodwin 
et al., 2005; Rocks et al., 2005). Our unpublished observations elucidated that at least a 
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pool of Rin1 is also found at the Golgi where it co-localises with markers such as GM130 
and GM97 and N-Ras (data not shown). It will be interesting to uncover the physiological 
role of the potential interaction of Rin1 and N-Ras at the Golgi. 
Among the remaining proteins obtained, we found a number of molecules involved in the 
protein transcription, translation and folding machinery, such as a RNA-Pol II subunit, RPLP1 
(60S acidic ribosomal protein P1), the heat shock protein HSPB1 and PFDN2 (Prefoldin 
subunit 2), respectively which could be artefacts due to the exogenous overexpression of 
TAP-tagged Rin1. Furthermore we found a number of proteins involved in the degradative 
machinery of the cell, such as proteasome subunits PSMA2, PSMA5 and PSMA7, also 
possibly artefacts due to aforementioned reason.  
Potentially relevant candidates however, were also identified. ITM2b, an integral 
membrane protein has been associated with familial British dementia (FBD), and in addition 
binds to and modulates APP (amyloid precursor protein) processing (Choi et al., 2004; 
Fotinopoulou et al., 2005; Matsuda et al., 2005). Intriguingly, another identified interactor, 
Presenilin 1 (Koo and Kopan, 2004), is an endoprotease that also plays an important role 
in processing APP and Notch receptor (Selkoe and Kopan, 2003). It localises to the Golgi 
apparatus but is also found associated with Notch at the plasma membrane. It is possible 
that both Presenilin 1 and ITM2b bind directly to Rin1 or this could be an example where a 
tertiary, indirect interactor has been purified.  
HAX1 (Suzuki et al., 1997) may function in promoting cell survival and is in addition thought 
to interact with cortactin, a molecule involved in endocytosis and golgi organisation 
(Radhika et al., 2004). 14-3-3 isoform eta has been shown to activate tyrosine and 
tryptophan hydroxylases in the presence of Ca2+/calmodulin-dependent protein kinase II 
(CAMKII), and strongly activates protein kinase C (Davare et al., 2004; Skoulakis and 
Davis, 1998). 14-3-3 isoform tau is also present in neurons and gets axonally transported 
to nerve terminals (UniProtKB/Swiss-Prot). Microtubule-associated protein 1B (MAP1B), has 
been implicated in cytoskeletal rearrangement during neurite extension among many other 
roles in the nervous system (Gonzalez-Billault et al., 2004). Stomatin-like2 (SLP-2) is also a 
cytoskeleton-associated protein that was found in a mass spectrometry analysis of activity-
dependent changes in PSD composition (Satoh et al., 2002) and has recently been isolated 
from caveolin-rich fractions of endothelial membranes (Sprenger et al., 2004).  
Further experiments will be needed to confirm the specificity of the interactions between 
Rin1 and these potentially interesting candidates and to elucidate the role that Rin1 plays 
in the diverse processes that these interactors have been implicated in. 
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3.2 Rin1 expression 
 
Several control experiments confirmed the specificity of the rabbit polyclonal antibody 
against murine Rin1 generated in our laboratory. These included stainings on 
overexpressed and endogenous Rin1 in cell lines and primary hippocampal neurons using 
pre-immune serum as a negative control (Figures 18 and 20). Furthermore we performed 
Western blots on Rin1wt and knockout forebrain lysates (Figure 19) and observed a strong 
similarity between expression patterns obtained by in situ and antibody staining methods 
(data not shown). We could show that compared to controls, the serum of rabbit #1203 
used throughout this study revealed specific staining and detected a clear band in Western 
blot corresponding to the expected size of Rin1. Further experiments allowed us to localise 
Rin1 to synaptic structures in primary hippocampal cultures and in coronal slices of adult 
mouse brain through co-localisation of Rin1 protein with synaptic markers Synaptophysin 
and PSD-95 (Figure 22, Figure 25) as well as detection of Rin1 in synaptosome and PSD 
preparations from adult mouse forebrain (Figure 32, Figure 33). As described before 
(Dhaka et al., 2003), we found no Rin1 expression during embryonic development (Figure 
23) and with the exception of the thalamus where we observed rin1 mRNA distributed in a 
“salt-and pepper” fashion (Figure 26, panel D), our expression data corresponded to 
published patterns (Dhaka et al., 2003). The riboprobe used in this study was of a different 
design than the one used in the study by Dhaka et al, thus we hypothesise that the 
discrepancy in detection of rin1 in the thalamus could be due to the sequence differences 
and regions covered by the different probes. In situs on adult mouse brain revealed a 
striking similarity between the expression patterns of rin1 and ephA4 which lead us to 
investigate the potential interaction between these two molecules. Additional in situs were 
performed with specific riboprobes against the other two Rin family members, Rin2 and 
Rin3 (Kajiho et al., 2003; Kimura et al., 2006; Saito et al., 2002). In contrast to published 
expression patterns on commercially available northern blot membranes for these two 
molecules we found expression of both in the adult brain (data not shown). We detected 
very weak expression of both in all regions of the hippocampus and in some areas of the 
cortex. In addition, rin3 mRNA was localised in the thalamus but neither rin2 nor rin3 
messages could be detected in the amygdala. We hypothesise that the absence of other 
Rin family members in the amygdala is the reason for the published enhanced LTP seen in 
Rin1 knockout mice, since the Rin1 null mutation cannot be compensated. In other regions of 
the nervous system and possibly other parts of the organism, however, absence of Rin1 
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might be compensated by Rin2 and/or Rin3 and thus no obvious phenotypes could be 
observed. 
 
 
3.3 Tyrosine phosphorylation of Rin1 
 
It has been proposed many years ago that signalling initiated by external stimuli is 
propagated inside cells through cascades of sequentially interacting signal transducers. 
Tyrosine phosphorylation and subsequent phospho-tyrosine dependent protein-protein 
interaction has emerged as one of the most important means through which this is achieved.  
In addition, although this is not a general rule, tyrosine-phosphorylation is commonly thought 
to be an activating modification of proteins, whereas de-phosphorylation by phosphatases 
is thought to be inactivating (Cohen, 1992; Koch et al., 1991; Pawson and Schlessingert, 
1993; Posada and Cooper, 1992).  
The role and nature of tyrosine phosphorylation has been previously addressed by Colicelli 
and colleagues for the human Rin1 (Afar et al., 1997). These authors employed an assay in 
Rat-1 cell fibroblasts which showed anchorage-independent growth in soft agar upon 
transformation with the P185 isoform of BCR/Abl. A mutant of BCR/Abl (Y793F) no longer 
had transforming capabilities but this could be rescued by overexpression of Rin1 and 
depended on three phosphorylatable tyrosines in Rin1. Furthermore the authors suggested 
that tyrosine phosphorylation of Rin1 stabilises its interaction with BCR/Abl by binding to 
the SH2 domain of BCR/Abl (Afar et al., 1997).  
Intrigued by the mapping of phosphorylatable tyrosines shown by these authors, we 
expressed (in preliminary experiments) murine Rin1 Y to F point mutants of tyrosines 
predicted to be phosphorylated (http://www.cbs.dtu.dk/services/NetPhos/) in HeLa cells in 
the presence of the phosphatase inhibitor sodium-ortho-vanadate and found Y35 to show 
the strongest reduction in overall phospho-tyrosine signal (data not shown). However, we 
were more interested in the upstream signals that can induce Rin1 phosphorylation and 
found Rin1 to be phosphorylated in response to activation of endogenously expressed RTKs 
such as TrkA, TrkB and cMet in the human neuroblastoma cell line SK-N-BE2 (Figure 28, 
Figure 29), albeit with slightly different kinetics. Differences in the time courses of Rin1 
phosphorylation possibly reflect the distance of Rin1 in the signalling cascade from the 
activated RTK. For future experiments it will be of great interest to determine the function 
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of Rin1 in signalling events initiated by the growth factors shown here to induce Rin1 
phosphorylation. 
Since we were interested in the relationship between Rin1 and EphA4, we investigated Rin1 
phosphorylation downstream of a related Eph receptor, EphB2, which is endogenously 
expressed in SK-N-BE2. We could not find a system in which both EphA4 and Rin1 were 
endogenously expressed and deemed it unsuitable to exogenously express EphA4 since it 
has been shown before that overexpression of Eph receptors leads to their constitutive 
activation as assessed by their phosphorylation state. By stimulating EphB2 with one of its 
ligands, ephrinB2, we detected a strong but transient phosphorylation of Rin1 on tyrosine 
(Figure 30). Since we could observe this inducible, Eph-mediated modification of Rin1, we 
propose to place Rin1 downstream activated Eph receptors. 
 
 
3.4 Rin1 interaction with EphA4 receptor 
 
It has been previously shown that human Rin1 and the Drosophila homologue Sprint are 
able to interact with several RTKs, such as EGFR, FGFRII, PDGFR, IR and PVR, respectively, 
by co-immunoprecipitations from cells, GST-pulldowns and yeast two-hybrid assays 
(Barbieri et al., 2003; Jekely et al., 2005). In all of these experiments the interaction was 
shown to be phospho-tyrosine dependent and mediated by the SH2 domain of Rin1. Most 
intensely studied was the binding of Rin1 to the EGFR (Barbieri et al., 2003). 
I found endogenously expressed human Rin1 to co-immunoprecipitate with endogenous 
cMet from SK-N-BE2 cells in a stimulation dependent manner (data not shown), an 
interaction which has not been reported before in the literature. More experiments will 
follow this observation in the future, especially with regard to the findings of Colicelli and 
colleagues who showed that Rin1 is a negative regulator of HGF mediated migration in 
mammary epithelial cells (Hu et al., 2005). So far, we did not further pursue the 
involvement of Rin1 downstream cMet as we wanted to concentrate on the relationship 
between Rin1 and EphA4 in this study. 
I found Rin1 to co-immunoprecipitate with EphA4 from transfected HeLa cells (Figure 31). 
Taking previous findings into consideration, I tried to determine whether the interaction of 
Rin1 and EphA4 was also mediated by phosphorylated tyrosines (potentially in the 
cytoplasmic tail of the receptor) and the SH2 domain of Rin1. We approached this question 
by mutating a critical arginine residue in the conserved FLVR motif of the SH2 domain of 
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Rin1 (R93E) but found that Rin1R93E co-precipitated with EphA4 just as well as the wt Rin1 
protein (Figure 31, panel A). Even a Rin1 mutant protein lacking the entire SH2 domain 
showed no impaired interaction with EphA4 (Figure 31, panel B). Preliminary data also 
suggests that EphA42E is still able to bind to Rin1 (data not shown) although it lacks the two 
JM tyrosines that upon phosphorylation constitute docking sites for SH2 interactors. As 
already described in chapter 1.1, there are several features that distinguish Eph receptors 
from other RTKs. Although so far we cannot base our predictions on experimental data, one 
can envision that Rin1 could directly interact with EphA4 through a SH2-independent 
mechanism. Possibilities include protein-protein interactions with the SAM domain, the kinase 
domain, the PDZ-binding motif or higher order clustering of the receptor that might recruit 
adapters that link EphA4 to Rin1. 
I was furthermore able to demonstrate an interaction between these two molecules in co-
immunoprecipitations from synaptic membrane material obtained from adult mouse 
forebrains (Figure 34). Since my in vitro experiments showed that the SH2 domain of Rin1 is 
dispensable and I observed a binding of Rin1 to EphA4 in vivo, we speculate that the 
interaction between the two proteins occurs through a mechanism different to the one 
previously published for other RTKs. 
 
 
3.5 Endocytosis of EphA4 is regulated by Rin1 
 
Only recently has endocytosis been appreciated as a process that is tightly linked and 
probably inseparable from signalling events taking place inside cells (Cavalli et al., 2001; 
Clague and Urbe, 2001; Sorkin and Von Zastrow, 2002) . Endocytosis itself is modulated 
by signalling pathways but the endocytic machinery in turn provides an architectural 
framework in which spatial and temporal control over signal prolongation or attenuation 
can be exerted (Hoeller et al., 2005; Polo and Di Fiore, 2006). As already discussed in 
chapter 1.3, the route as well as the purpose of endocytosis can vary even when examining 
the internalisation of only a single RTK. Studies on RTK endocytosis include work on 
numerous growth factor receptors, such as TrkA (Delcroix et al., 2003; Shang et al., 2004), 
cMet (Hammond et al., 2003; Kamei et al., 1999), TGFß-R (Di Guglielmo et al., 2003) and 
especially EGF-R (Barbieri et al., 2003; Barbieri et al., 2000; Sigismund et al., 2005). 
Very little however, is known about regulation or function of Eph receptor internalisation. 
Eph receptor endocytosis was recently proposed as a means to achieve disruption of cell-
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cell contact initiating Eph-ephrin mediated repulsion (Cowan et al., 2005; Marston et al., 
2003; Zimmer et al., 2003). Although there is evidence that Rac-mediated rearrangement 
of the actin cytoskeleton is required in the Eph receptor expressing cell (Marston et al., 
2003), it remains unclear what route the internalised receptor takes, how this process is 
controlled and what purpose it serves.  
In this study I could show that stimulation with ephrinB3 leads to endocytosis of EphA4 and 
subsequent appearance in Rab5 positive endosomes. I observed this phenomenon in HeLa 
cells stably expressing EphA4 (Figure 35), as well as in primary hippocampal neurons and 
glia cells (Figure 36). Preliminary data obtained through immunofluorescence stainings in 
primary neurons and glia also showed co-localisation of the internalised Eph receptor with 
strong phospho-tyrosine signals (anti-phospho-tyrosine antibody, data not shown). This 
finding is indicative of still active receptor-ligand complexes, which correlates with the 
observations of Nobes and colleagues in fibroblasts (Marston et al., 2003). Furthermore, 
upon stimulation of neurons with ephrinB3-expressing HeLa cells, we found the GTPase 
Dynamin (responsible for the fission of invaginated pits) present on the receptor side of the 
formed complexes (using an antibody against the neuron-specific isoform of Dynamin), 
indicative of an involvement of Dynamin in the endocytosis of Eph receptors (data not 
shown). Further experiments are in preparation to characterise the Eph internalisation 
pathway in more detail. These include staining procedures using markers for components of 
the endocytic machinery and biochemical analysis of the Eph receptor for modifications 
involved in endocytosis such as ubiquitination. It will also be worthwhile to dissect the 
possibly diverse routes of EphA4 internalisation initiated through binding of either ephrinA 
or ephrinB ligands. 
 
Since I have successfully established an interaction of Rin1 and EphA4 (Figures 31 and 34) 
and have observed trafficking of EphA4 through Rab5 endosomes (Figures 35 and 36), I 
investigated whether Rin1 regulates the internalisation of EphA4. It has been shown 
previously that Rin1 exerts a positive influence on EGFR endocytosis through its action as a 
Rab5GEF (Barbieri et al., 2003; Tall et al., 2001). Our data provides evidence that Rin1 
also positively regulates EphA4 endocytosis. Using a surface biotinylation assay, I observed 
enhanced EphA4 internalisation in HeLa cells stably expressing this receptor when 
transfected with full-length Rin1 as compared to control (eGFP) transfected cells (Figure37). 
Further support for this finding was obtained through a quantitative analysis of internalised 
receptor-ligand clusters in the same cells by immunofluorescence stainings. We observed an 
average increase of EphA4 endocytosis from 19% in control cells (eGFP transfected) to 
29% in cells expressing the Rin1 full-length construct (Figure 40). In addition to this 
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promising gain-of-function data, we designed dominant negative versions of Rin1, either 
lacking the entire catalytic (GEF) domain (Rin1ΔGEF) or the C-terminal end of the GEF 
domain (Rin1-splice), a deletion that corresponds to a naturally occurring splice variant of 
Rin1 shown to be catalytically inactive (Han et al., 1997; Tall et al., 2001). When applied 
in the surface biotinylation experiment, I could demonstrate that overexpression of either 
Rin1ΔGEF or Rin1-splice reduced the amount of endocytosed EphA4 to control levels (Fc 
stimulated). No specific induction of ephrinB3 induced internalisation that also occurs in 
eGFP transfected samples could be seen in case of the dominant-negative constructs (Figure 
41). Thus we conclude that Rin1 is an important positive regulator of EphA4 endocytosis. For 
a schematic model incorporating the aforementioned data, please refer to Figure 43. 
 
 
 
Figure 43 Rin1 is an essential regulator of EphA4 endocytosis 
(1) In the absence of ligand stimulation there appears to be a constitutive internalisation of 
EphA4 since even mock (Fc) stimulated samples in the surface biotinylation show very low levels 
of internalised receptor. Comparable residual levels were observed when GEF-deficient, 
dominant-negative forms of Rin1 were used in this assay. 
(2) In untransfected conditions or when expressing a control protein (eGFP) we observed a 
ligand-dependent induction of EphA4 endocytosis and found EphA4 in Rab5 endosomes 
(3) Expression of full-length Rin1 results in increased EphA4 endocytosis when compared to 
eGFP transfected control samples in surface biotinylation assays or when quantifying 
internalisation rates in immunofluorescence experiments 
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It is intriguing to speculate that internalisation of Eph receptors might in some contexts lead 
to signal attenuation, especially since very little is known about negative regulation of Eph 
receptors. Elegant work from Noda and colleagues recently provided evidence that 
Phospho-tyrosine phosphatase receptor type O (Ptpro) can specifically de-phosphorylate 
Ephs (including EphA4) thus reducing the activity state of the receptors. The authors 
furthermore showed that Ptpro controls the sensitivity of Eph expressing retinal axons 
towards ephrins and has a crucial role in the establishment of topographic projections in 
vivo (Shintani et al., 2006). These findings however, do not exclude the existence of 
additional mechanisms such as endocytosis that might downregulate the activity of Eph 
receptors and it is even possible that regulation of the phosphorylation state of the receptor 
is involved in the events necessary for internalisation (Han et al., 2006; Levkowitz et al., 
1999). 
 
 
3.6 EphA4-/- mice have a LTP defect in the amygdala 
 
Plasticity and memory formation involves many of the molecules and cellular processes 
described in chapter 1, their specific roles in modulating synaptic transmission shall be 
made clear in the following paragraph to help the appreciation of our current data. 
In analogy to the hippocampal system, amygdala LTP is believed to be a cellular model for 
the acquisition of fear conditioning or learning. It involves the convergence of neural inputs 
from the conditional and unconditional stimulus (CS and US, respectively) onto lateral 
amygdala (LA) neurons during training (Blair et al., 2001; LeDoux, 2000; Maren, 2001). In 
protocols used to elicit LTP it involves a high frequency stimulus (HFS) applied to input 
pathways to the LA. LA neurons have been shown to increase their firing rates to the CS 
when paired with the US (reviewed in (Maren and Quirk, 2004)). 
NMDA receptors (NMDARs), as well as delivery of (GluR1 containing) AMPA receptors 
(AMPARs) into synapses have been shown to be essential for acquisition of fear memory 
(Goosens and Maren, 2004; Maren, 2005; Rodrigues et al., 2004; Rumpel et al., 2005). 
Ca2+ influx through NMDARs and additionally, through voltage gated Ca2+channels 
(VGCCs) induces a second messenger cascade that converges on Ras-MAPK pathway and 
ultimately ends in CREB-induced transcription necessary for fear consolidation or long-term 
memory (Rodrigues et al., 2004). Malinow and colleagues provided evidence that at 
excitatory synapses in the hippocampus, Ras mediates NMDAR (and CAMKII) signalling that 
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drives synaptic delivery of AMPARs during LTP (Zhu et al., 2002) but studies in the 
amygdala have also implicated Ras-Erk signalling in memory formation (Atkins et al., 1998; 
Brambilla et al., 1997; Schafe et al., 2000).  
Eph receptors and ephrins regulate synaptic plasticity through both forward and reverse 
signalling and mouse mutants have been analysed for their plasticity defects in the 
hippocampus ((Armstrong et al., 2006; Contractor et al., 2002; Grunwald et al., 2004) and 
reviewed in (Klein, 2004; Yamaguchi and Pasquale, 2004). Eph(B2) receptor signalling, for 
example has been suggested to potentiate NMDAR-dependent Ca2+ currents and 
transcription factor activation (Battaglia et al., 2003) and absence of EphB2 leads to a 
reduction of synaptic NMDARs (Henderson et al., 2001). To our knowledge, the role of Eph 
receptors in synaptic plasticity in the amygdala has not been addressed prior to the study 
presented here. 
  
Recent work has emphasised the role of Rab GTPases in synaptic plasticity. Rab8, a 
GTPase associated with the TGN and the PSD has been shown by Esteban and colleagues 
to be involved in local delivery of AMPARs to the spine-surface at the post-synapse and a 
dominant negative Rab8 blocked LTP expression (Gerges et al., 2004). NMDAR-dependent 
activation of Rab5 on the other hand drives the removal of synaptic AMPARs at excitatory 
CA3-CA1 synapses in the hippocampus, a process that is both necessary and sufficient for 
LTD (Brown et al., 2005). Although Colicelli and colleagues could not detect LTP defects in 
Rin1 mutant mice in the hippocampus (Dhaka et al., 2003), preliminary results from our 
laboratory suggest that Rin1-/- mice display LTD defects in Schaffer collateral synapses. 
We hypothesise that this is due to the same mechanisms described for Rab5 in removing 
AMPARs from the PSD (Brown et al., 2005). 
Rin1 has previously been suggested to act as a negative regulator of learning and memory 
in the amygdala as Rin1 mutant mice show enhanced fear memory and increased LTP 
(Dhaka et al., 2003). The authors speculate that this is achieved through competition with 
the Ras effector Raf, thus diverting from the Ras-Raf-MAPK pathway involved in memory 
and plasticity of excitatory neurons (reviewed in (Weeber and Sweatt, 2002) and refer to 
Figure 13) or away from other Ras effectors, such as PI3K, also shown to play a role in 
amygdala plasticity (Lin et al., 2001). Other possibilities considered in this publication 
concern the enhancement of Abl1 and Abl2 signalling by Rin1, potentially involved in 
cytoskeletal modification of synapses. The last hypothesis brought forward by these authors 
states that Rin1 through its role as a Rab5GEF might lead to internalisation of a yet 
unknown receptor that positively regulates LTP in the amygdala.  
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Since our current data show that EphA4 null mutant mice are defective in amygdala LTP 
(Figure 42, panel B), we favour the latter hypothesis. One logical conclusion of reduced 
receptor endocytosis would be increased levels of receptors in the postsynaptic membrane 
of LA neurons leading to prolonged signalling, and concomitant increased LTP. We are at 
present trying to evaluate whether we can observe increased levels of EphA4 at the 
membrane of LA neurons in Rin1-/- mice. A system in which this question can be addressed 
has proven to be of great technical complexity.  However, we have developed an explant 
system for the lateral amygdala from mice (two to three weeks of age) in which we can 
observe single neurons. We plan to challenge wt and Rin1-/- explants with ephrin ligands 
and assess the internalisation rate of EphA4 by quantification of pre- and post-
permeabilisation stainings (described in chapter 2.6 and in the Methods section).  
Our data suggest that EphA4 fits the requirements of a receptor that positively regulates 
plasticity in the amygdala as indeed its absence prevents LTP. It remains to be elucidated 
how EphA4 signalling influences known molecular events important for LTP expression. One 
can envision that EphA4 in analogy to EphB2 in the hippocampus (see above) might be 
involved in enhancing NMDAR signals. Integrating also our results that advocate Rin1 as a 
positive regulator of EphA4 endocytosis, the complementary phenotypes of Rin1 and EphA4 
mutant mice suggest the model presented in Figure 44 that incorporates the results obtained 
in our current study. 
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Figure 44 Involvement of Rin1 and EphA4 in amygdala LTP 
(A) Under wt conditions, both EphA4 and Rin1 are present in neurons of the lateral amygdala 
and normal LTP can be induced in these animals. 
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(B) Rin1 knockout mice have been shown to display elevated LTP in the amygdala (Dhaka et 
al., 2003). We propose in this model that the absence of Rin1 leads to reduced internalisation 
of EphA4, potentially a concomitant increase of EphA4 at the membrane. We hypothesise that 
increased signalling downstream EphA4 is responsible for the elevated amygdala LTP. 
(C) Mice lacking the EphA4 receptor are deficient in amygdala LTP as shown in this study. We 
propose that the lack of EphA4 mediated signalling is responsible for the plasticity defect. 
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4 Materials and Methods 
 
4.1 Materials 
 
4.1.1 Mouse lines 
 
EphA4-/- (ephA4TAC) were generated by Klas Kullander (Neuron 2001 and Science 
2003) and maintained in a mixed 129xC57Bl/6 background. For experiments, offspring of 
heterozygous intercrosses was used. 
 
Rin1-/- mice were generated by Dhaka et al, J Neurosci., 2003 and maintained in a 
C57Bl/6 background. For experiments, offspring of heterozygous intercrosses was used. 
 
 
4.1.2 Bacteria 
 
XL2-blue, chemically competent cells (Stratagene) 
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F'proAB lacIqZÄM15 Tn10 
(Tetr) Amy Camr]a 
TOP10 (Invitrogen) 
DH5α (Invitrogen) 
BL21 (Invitrogen) 
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4.1.3 Plasmids 
 
Backbone/   
Insert Comments Reference 
   
mammalian expression 
 
 
Rin1-CTAP Cterm TAPtag (CBP, TEV, ProtA) for proteomics Cellzome/ 
K.Deininger 
   
pcDNA3.1   
   
EphA4-wt FL wt EphA4-Receptor K. Kullander 
EphA4-KD Kinase dead EphA4-Receptor K. Kullander 
EphA4-2E 2 juxta-membrane Y’s mutated K. Kullander 
EphA4-eGFP Cytopl. tail replaced by eGFP K. Kullander 
   
pcDNA3.1mycHis   
   
Rin1-FL complete cds K. Deininger 
Rin1-SH2aa1-166 SH2 domain K. Deininger 
Rin1 Ctermaa477-763 GEF, RA domains K. Deininger 
Rin1-ΔSH2aa170-763 poly-P, GEF, RA K. Deininger 
Rin1-splice  ≅ nat. occ. splice variant  
delta aa 418-479 
K. Deininger 
Rin1-Δaa431-615 delta GEF domain K. Deininger 
Rin1-Ntermaa1-430 delta GEF, RA domains K. Deininger 
Rin1-R93E SH2 domain point mutant K. Deininger 
Rin1-Y35F Tyr 35 to Phe point mutant K. Deininger 
Rin1-Y283F Tyr 283 to Phe point mutant K. Deininger 
Rin1-Y670F Tyr 670 to Phe point mutant K. Deininger 
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Figure 45 Rin1 overexpression constructs 
Shown is a schematic representation of Rin1 overexpression constructs in the pcDNA3.1mycHis 
backbone. Domains from left to right (N-term to C-term):  
(SH2, dark grey box) src homology 2 domain, (PxxP, dark grey bars) poly-proline motif 
involved in SH3 domain binding, (S340, light grey bar), 14-3-3 binding motif including the 
crucial serine 340, (GEF, light grey box) guanine nucleotide exchange factor domain, (RA, 
grey box) conserved Ras association domain. 
 
   
pEGFP_C1   
   
Rin1-Ctermaa268-763 Nterm.GFPtag K. Deininger 
Rin1-SH2aa60-151 Nterm.GFPtag K. Deininger 
   
   
pEGFP_C3   
   
Rab5-Q79L Nterm.GFPtag M. Zerial 
Rab5a-wt Nterm.GFPtag M. Zerial 
   
pEGFP_C2   
   
Rab5-S34N Nterm.GFPtag M. Zerial 
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Nras-wt GFP- or myc-tagged B. Short / F. Barr 
Nras-Q61L GFP- or myc-tagged B. Short / F. Barr 
Hras-wt GFP- or myc-tagged B. Short / F. Barr 
Hras-Q61L GFP- or myc-tagged B. Short / F. Barr 
 
bacterial expression 
 
pDEST15   
Rin1FL Nterminal GST fusion protein K. Deininger 
 
pDEST17 
  
Rin1FL Nterminal His6 fusion protein K. Deininger 
   
 
in situ probes 
 
pCR2.1-TOPO   
Rin13’UTR 5’-3’ insertion, digested EcoNI 
= antisense probe 
K. Deininger 
 3’-5’ insertion = sense probe K. Deininger 
   
pCMV-SPORT6   
Rin2 digested AccI or BglII K. Deininger 
   
pCMV-SPORT2   
Rin3 digested DrdI K. Deininger 
   
pBSKS   
EphA4 digested XhoI F. Helmbacher 
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4.1.4 Chemicals, kits, enzymes and other reagents 
 
All chemicals were purchased from Sigma, Merck, Serva, and Roth unless specified 
otherwise in the Methods section. All water used in solutions and reaction mixes was filtered 
through a “Milli-Q-WaterSystem” (Millipore). Restriction and modifying enzymes were 
obtained from New England Biolabs (NEB). Plasmid Mini- and Maxi-preparations were 
done using the QIAGEN QIAprep Spin Miniprep or the Plasmid Maxi Kits, respectively. 
QIAquick PCR Purification and Gel Extraction kits were used in cloning procedures when 
necessary. Mutations were introduced using the QuikChange Site-directed Mutagenesis Kit 
(Stratagene). 
 
 
4.1.5 Media 
 
4.1.5.1 Media and Antibiotics for bacterial culture 
 
 
LB (Luria-Bertani) media   10g Bacto-Trypton 
      5g Yeast extract 
      5g NaCl 
      Add H2O to 1L, pH to 7.5 
 
SOC      10g Bacto-Tryptone 
      2.5g Bacto-Yeast extract 
      0.25g NaCl 
      5ml 250mM KCl 
      2.5 ml 2M MgCl2  
      Add H2O to 500ml, pH to 7.0 
      Add 10ml 1M sterile Glucose solution 
 
LB plates     supplement with 15g/L agar 
 
Antibiotics     diluted 1:1000 from stock solutions: 
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Ampicillin     100mg/ml in H2O 
Kanamycin     50mg/ml in H2O 
Tetracyclin     5mg/ml in Ethanol 
 
4.1.5.2 Primary culture media, reagents, growth factors and stimulants 
 
HBSS    Gibco 
 
Dissociation media  500ml HBSS, supplemented with 1% Penicillin/  
    Streptomycin (Gibco), 3.5ml HEPES (1M, pH7.5) and 5ml  
    MgCl2 (1M) 
 
Neurobasal media/B27 Gibco, 500ml supplemented with 10ml B27 supplement  
    (Gibco) 
 
Poly-D- or L-Lysine  Sigma, dissolved 1mg/ml in borate buffer 
 
Mouse-Laminin   Gibco, dissolved 5μg/ml in PBS (Sigma) 
 
Papain   Sigma, dissolved 10mg/ml in H2O 
 
Inhibitor solution  Trypsin inhibitor (Roche), diluted 10mg/ml in dissociation 
    media, neutralized with NaOH 
 
Growth factors  NGF (R&D), used at 100ng/μl 
     BDNF (R&D), used at 20ng/ml 
     HGF (R&D), used at 40ng/ml 
     PDGF (Sigma), used at 30ng/ml 
 
Stimulants   Fc, Eph-Fc and ephrin-Fc fusion proteins were purchased 
    from R&D and used at 1μg/ml 
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4.1.5.3 Media for cell lines 
 
HeLa    DMEM, 10% FBS, 1% Glutamine, 1% pen/strep 
Stable HeLa   DMEM, 10% FBS, 1% Glutamine, 1% pen/strep, 400ng/ml  
Geneticin (Gibco) 
Cos    DMEM, 10% CS, 1% Glutamine, 1% pen/strep 
NIH/3T3   DMEM, 10% CS, 1% Glutamine, 1% pen/strep 
SK-N-BE2   OptiMEM with Glutamax, 10% ISCS (iron-supplemented  
calf serum), 1% pen/strep 
 
 
4.1.6 Buffers and solutions 
 
All buffers and solutions not described in detail were prepared according to standard 
protocols as described in “Short Protocols in Molecular Biology”, John Wiley & Sons, Inc., 
1999 
 
Borate buffer   1.2g boric acid 
    1.9g sodium borate (Borax) 
    Add H2O to 500ml and pH to 8.5 
 
Cell lysis buffer  50mM Tris·HCl, pH 7.5 
    150mM NaCl 
    0.5% TritonX·100 
per 50ml: 1 tablet “complete” protease inhibitor cocktail 
(Roche), 0.22g NaPPi, 0.04g NaF, 1mM Vanadate 
 
 
Solutions for postsynaptic density fractionation 
 
Solution A   0.32M sucrose, 20mM HEPES (pH 7.4), 10mM NaF, 1mM  
    Na3VO4, 1mM PMSF, protein inhibitor cocktail (Roche) 
Solution B   0.32M sucrose, 20mM HEPES (pH 7.4) 
Solution C   12mM Tris (pH 8.0), 1% TritonX-100 
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Solution D   40mM Tris (pH 8.0) 
Solution E   12mM Tris (pH 8.0), 6% sarcosyl (N-lauryl-sarcosine) 
 
Reducing sample buffer for SDS PAGE  300mM Tris·HCl pH 6.8 
       12% SDS 
       600mM DTT 
       0.6% (w/v) BromoPhenolBlue 
       60% glycerol 
 
Tandem Affinity Purification (TAP) solutions 
 
Lysis buffer  50mM Tris-HCl, pH 7.5 
5% Glycerol 
0.2% NP-40 
1.5mM MgCl2 
1mM DTT 
100mM NaCl 
Add fresh: 
50mM NaF 
1mM Na3VO4 
2µM microcystine-LR 
Protease inhibitor cocktail tablet (complete), 
EDTA-free 
TEV Cleavage buffer  10mM Tris-HCl, pH 7.5 
100mM NaCl 
0.1% NP-40 
0.5mM EDTA 
1mM DTT 
CBP wash buffer  10mM Tris-HCl, pH 7.5 
100mM NaCl 
0.1% NP-40 
1mM MgAc 
1mM Imidazole 
2mM CaCl2 
1mM DTT 
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2x CBP dilution buffer (TAP) 10mM Tris-HCl, pH 7.5 
100mM NaCl 
0.1% NP-40 
2mM MgAc 
2mM Imidazole 
4mM CaCl2 
1mM DTT 
CBP elution buffer (TAP) 10mM Tris-HCl, pH 8.0 
5mM EGTA 
 
 
 
4.1.7 Antibodies 
 
Primary antibodies 
 
antibody species company appl. dilution 
     
anti-phosphoMAPK mouse monoclonal 
clone E10 
Cell Signaling WB 1:2000 
anti-MAPK rabbit polyclonal Cell Signaling WB 1:1000 
anti-Tubulin mouse monoclonal Sigma WB 1:10000 
anti-eXFP mouse monoclonal BD Clontech WB 1:1000 
anti-pan-ras mouse monoclonal 
Ab3 
Calbiochem 
Oncogene Res.  
WB 
IP 
1:1000 
1μg 
anti-Nras mouse monoclonal 
clone F155-227 
Calbiochem 
Oncogene Res. 
WB 1:1000 
anti-Rab5a mouse monoclonal 
clone15 
BD Pharmingen WB 1:500 
anti-Rin1 rabbit polyclonal BD Pharmingen WB 
IP 
IF 
1:500 
1μg 
1:100 
 rabbit polyclonal In house WB 
IP 
1:1000 
2μl 
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IF 
IHC 
1:100 
1:1000 
anti-phospho-
Tyrosine 
mouse monoclonal 
clone 4G10 
Upstate IF 
WB 
1:100 
1:1000 
anti-myc mouse monoclonal Ascites, in house WB 1:1000 
 conjugated to Cy3  IF 1:100 
anti-Clathrin HC goat polyclonal Santa Cruz IF 1:100 
anti-PSD95 mouse monoclonal 
clone 7E3-IB8 
Sigma WB 
IF 
1:2000 
1:100 
anti-Synaptophysin mouse monoclonal 
MAB5258 
Chemicon? IF 
WB 
1:100 
1:1000 
anti-Synapsin mouse monoclonal 
clone 46.1 
SySy IF 
WB 
1:500 
1:10000 
anti-GluR2 mouse monoclonal 
MAB397 
Chemicon WB 
IF 
1:1000 
1:100 
anti-GluR2&3 rabbit polyclonal Chemicon IP 2μg 
anti-LAMP1 mouse monoclonal 
LY1C6 
Abcam  IF 1:100 
anti-Dynamin1 mouse monoclonal 
clone 4E67 
Abcam IF 1:100 
anti-Caveolin rabbit polyclonal Abcam (ab2910) IF 1:100 
anti-γAdaptin mouse monoclonal 
clone 88 
BD Pharmingen IF 1:100 
anti-TGN38 mouse monoclonal 
clone 2 
BD Pharmingen IF 1:200 
anti-GM130 sheep polyclonal from Francis Barr IF 1:1000 
anti-EphB2     
anti-EEA1 mouse monoclonal  
clone E41120 
BD Pharmingen IF 1:100 
anti-PKCμ (D-20) rabbit polyclonal Santa Cruz IF 1:100 
anti-EphA4 mouse monoclonal 
(anti-Sek) 
BD Pharmingen WB 1:2000 
 rabbit polyclonal In house IP 
WB 
1μl 
1:2000 
 rabbit polyclonal Santa Cruz IF 1:100 
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(S-20) 
     
anti-hFc goat polyclonal 
conjugated to Cy5 
conjugated to TR 
  
IF 
IF 
 
1:50 
1:50 
 
 
Secondary antibodies 
 
antibody conjugate species company appl. dilution 
      
anti-mouse HRP 
Cy3 
Cy5 
sheep polyclonal 
donkey 
donkey 
Amersham 
Jackson 
Jackson 
WB 
IF 
IF 
1:3000 
1:300 
1:300 
anti-rabbit HRP 
Cy3 
Cy5 
goat polyclonal 
donkey 
donkey 
Amersham 
Jackson 
Jackson 
WB 
IF 
IF 
1:5000 
1:300 
1:200 
anti-goat HRP rabbit polyclonal DAKO WB 1:4000 
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4.2 Methods 
 
 
4.2.1 Tandem Affinity Purification and mass spectrometry 
 
A retroviral transduction vector was generated by cloning the Rin1 open reading frame, 
amplified by polymerase chain reaction, into a Moloney-based vector with the Gateway 
site-specific recombination system (Invitrogen) to obtain a C-terminal TAP fusion. Virus stocks 
were generated in a HEK293 Gag–Pol packaging cell line. SK-N-BE2 cells were infected 
and complexes were purified by using a modified TAP protocol (Gavin et al., 2002; Rigaut 
et al., 1999). 40 15cm-dishes of  SK-N-BE2-Rin1-CTAP cells were harvested by mechanical 
detachment, washed with excess PBS on ice and lysed in 10ml lysis buffer each using a 
glass Teflon dounce homogenizer. Subsequently, lysates were incubated on a rotating 
wheel for 30min at 4°C and then centrifuged for 10min at 13000rpm, 4°C. The 
supernatant was added to 200µl rabbit IgG agarose (Roche) and rotated for 2h at 4°C. 
Beads were saved by centrifugation for 1min (1300rpm, 4°C, Varifuge 3.0R), transferred 
into a small column (0.8ml Mobicol M1002, MoBiTec) and washed with 10ml lysis buffer 
followed by a wash with 5ml TEV cleavage buffer. Beads were resuspended in 150µl TEV 
cleavage buffer and incubated upon addition of 4µl TEV protease (recombinant, 
Invitrogen) for 3h at 16°C in a thermoshaker (900rpm). The TEV eluate was directly 
applied to a Calmodulin affinity resin (214303-52, Stratagene) in a new column, mixed 
with 200µl CBP binding buffer and incubated for 1h at 4°C. Calmodulin beads were 
washed with 5ml CBP wash buffer and the protein complexes eluted with 600µl CBP elution 
buffer for 5min at 37°C. Both the CBP beads after elution and the lyophilized protein 
samples were boiled for 5min with 50µl 4x sample buffer (containing 20mM DTT) and 
separated by SDS–PAGE. Complete gel lanes were systematically cut into slices and 
proteins were digested in-gel with trypsin as described (Shevchenko et al., 1996). Protein 
identification was performed by LC–MS/MS at Cellzome AG, Heidelberg. MS data were 
searched against an in-house version of the International Protein Index (IPI), maintained at 
the EBI (Hinxton, UK). Results of database searches were subjected to further 
bioinformatical analysis. Proteins found repeatedly in complex purifications regardless of 
nature of the bait were classified as “sticky” and removed from the data list. 
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4.2.2 Cloning 
 
 
4.2.2.1 Rin1 cDNA 
 
Mouse Rin1 cDNA was obtained from RZPD (Clone IMAG p998O078934Q2) and correct 
sequence was verified by sequencing with the following primers: 
 
 
Rin2 and Rin3 cDNA was also obtained from RZPD, the clone identification numbers were 
IMAG p998n117646Q and IMAG p998G121372Q3, respectively. Commercially 
available primers flanking the multiple cloning sites of pCMV-SPORT6 and pCMV-SPORT2, 
the plasmid containing the Rin2 and Rin3 cDNAs, were used to sequence the respective 
inserts. 
 
 
4.2.2.2 Rin1 overexpression constructs 
 
All constructs were generated by PCR-amplifying specific regions of the rin1 gene with 
primers that usually contained convenient restriction sites for subcloning using the PFUultra 
DNA Polymerase (Stratagene) following vendor’s instructions. Details about the regions of 
rin1 gene covered in the various deletion constructs are described in the results section. All 
constructs were verified by sequencing with aforementioned sequencing primers. Mutations 
were introduced using the QuickChange Site-Directed Mutagenesis Kit (Stratagene), 
following vendor’s instructions. Primers used to amplify regions of the rin1 gene or to mutate 
specific sequences are as follows. 
 
seq1 
seq2 
seq3 
seq4 
seq5 
5’-GGA GGG CTC AGA GCT CAT GTT CC-3’ 
5’-CCA GCC AAA CGG AAA GAC TGC CC-3’ 
5’-CCG CCA GGC CCT AAG TCG GGC CC-3’ 
5’-GCT GAT GAG TTC CTG CCT CTG C-3’ 
5’-CCG AGT GAC CCA ACC AGA TGC G-3’ 
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construct 
 
primer sequences 
Rin1-cTAP  
sense 
 
antisense 
5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TAG ACT GCC ATG GAA 
GAC CCT GGT GAG ACC GGA GCA CAC-3’ 
5’-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA CTC TTC CAA AGC CTG 
GCT TCC TTC TGC-3’ 
 
Rin1FL  
sense 
antisense 
5’-GTG GTC GGA TCC GCC GCC ATG GAA GAC CCT GGT GAG-3’ 
5’-GGT TCT TCC TCT AGA CTC TTC CAA AGC C-3’ 
 
Rin1FL-R93E  
sense 
antisense 
5’-CCG GGG ACC TTC CTG GTG GAG AAA TCT AAC ACT CGC-3’ 
5’-GCG AGT GTT AGA TTT CTC CAC CAG GAA GGT CCC CGG-3’ 
 
Rin1FL-Y35F  
sense 
antisense 
5’-CCA TCT ACA GAC CCA CTG TTT GAC ACA CCT GAT ACC-3’ 
5’-GGT ATC AGG TGT GTC AAA CAG TGG GTC TGT AGA TGG-3’ 
 
Rin1FL-Y283F  
sense 
antisense 
5’-GGA GAG CTC AGT GGG ATT TCG TGT GCC AGG-3’ 
5’-CCT GGC ACA CGA AAT CCC ACT GAG CTC TCC-3’ 
 
Rin1FL-Y670F  
sense 
antisense 
5’-AGG ACC AGG GCT TCC ATC GCC TGC CCC-3’ 
5’-GGG GCA GGC GAT GGA AGC CCT GGT CCT-3’ 
 
Rin1- SH2aa 1-166 
 
sense 
antisense 
5’-CGG GGT ACC AGG CCG CCA TGG AAG ACC CTG GTG-3’ 
5’-CGG AAT TCG GAG ATG GCC TCC AGC TC-3’ 
 
Rin1- Ctermaa 477-763  
sense 
antisense 
5’-CGG GGT ACC AGG CCG CCA TGG CCC CAG TGG AGA CAG AAC AG-3’ 
5’-CGG AAT TCC TCT TCC AAA GCC TGG CTT CC-3’ 
 
Rin1- ΔSH2aa 170-763  
sense 
antisense 
5’-CGG GGT ACC AGG CCG CCA TGG AGT TCT GGA GCT CCT CAC-3’ 
5’-CGG AAT TCC TCT TCC AAA GCC TGG CTT CC-3’ 
 
Rin1- splice  
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For internal deletions (Rin1-splice and Rin1-ΔGEF), a 5’ piece upstream of the deletion and 
a 3’ piece downstream of the deletion were generated by PCR. Junction of the pieces was 
mediated via a EcoRI restriction site contained in the antisense primer for the 5’ part and 
the sense primer for the 3’ part. Two amino acids (Glutamic acid [E] and Phenylalanine [F]) 
were introduced which are coded by the two triplets comprising the EcoRI site. 
 
 
4.2.2.3 In situ probes 
 
For information about plasmids used for transcribing the in situ probes, please refer to the 
Materials section.  All antisense RNA probes were transcribed with T7 RNA polymerase. 
Rin1 antisense RNA was generated as follows. The last 300bp of rin1 coding sequence 
followed by 160bp of 3’UTR were amplified from IMAG p998O078934Q2 with the 
following primers: 
 
sense:  5’-TTG GCC TCT TCC TCT ACA AGG-3’ 
antisense: 5’-CCA GCT CCC TGT TCC CTA GC-3’ 
 
and subcloned into pCR2.1-TOPO vector. Bacterial clones were screened by restriction 
digestion to determine direction of insertion. Inverse orientation was used as template to 
transcribe a sense RNA probe, to be used as a control. 
(Δaa 418-479) 
sense for 5’- part 
antisense for 5’-  part 
sense for 3’- part 
antisense for 3’-  part 
5’-GCT GGT ACC GCC GCC ATG GAA GAC C-3’ 
5’-GCT GAA TTC CAG CCG CTC TGG TGG-3’ 
5’-GAT GAA TTC GAG ACA GAA CAG GTG C-3’ 
5’-CCA CTC GAG CTC TTC CAA AGC CTG G-3’ 
 
Rin1- ΔGEF  
sense for 5’- part 
antisense for 5’-  part 
sense for 3’- part 
antisense for 3’-  part 
 5’-GCT GGT ACC GCC GCC ATG GAA GAC C-3’ 
5’-CCA GAA TTC GAG AAC AGA GCG ATG C-3’ 
5’-GGT GAA TTC CTC CTC CGA GTA GCC-3’ 
5’-CCA CTC GAG CTC TTC CAA AGC CTG G-3’ 
 
Rin1- Ntermaa 1-430  
sense 
antisense 
5’-GCT GGT ACC GCC GCC ATG GAA GAC C-3’ 
5’-CCA CTC GAG AAC AGA GCG ATG CAG G-3’ 
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4.2.3 Antibody generation 
 
The purification of the recombinant protein used for generation of the anti-Rin1 antibody 
and the immunization of the rabbits and the goat were conducted in collaboration with 
Rodrigo Sanchez in our laboratory.  
For purification of the Rin1 recombinant protein, BL21 E.Coli were transformed with the 
expression plasmid pDEST17-His6-Rin1 containing the FL Rin1 cDNA by the heat shock 
method. Colonies were selected on an ampicillin supplemented LB agar plate, single clones 
inoculated into LB media and grown at 37ºC to the absorbance of 0.4 at OD750. Protein 
expression was then induced by adding 1mM isopropyl-D-1-thiogalactopyranoside (IPTG) 
to the culture and incubation for 2 hours at 30°C with constant agitation. The bacteria were 
pelleted at 4000 rpm in a 4°C centrifuge. The bacterial pellet was washed twice in cold 
PBS and resuspended in 20mM TRIS·HCl (pH 8) containing a cocktail of protease inhibitors 
(Roche) and 1mM DTT. The bacteria were mechanically lysed by passing the bacterial 
suspension 4 times through a French press. The sample was then centrifuged at 10.000 rpm 
for 10 min at 4°C and resuspended in binding buffer (6M guanidine hydrochloride, 20mM 
TRIS·HCl pH 8, 0.5M NaCl, 5mM imidazole, 1mM 2-mercaptoethanol) and kept stirring at 
RT for 60min before centrifugation at 10.000rpm for 15min at 4ºC. Remaining particles 
were removed by filtration through a 0.45μm filter. The recombinant protein used for 
antibody production was then purified by Fast Protein Liquid Chromatography (FPLC) using 
the ÄKTA EXPLORER FPLC device. In brief, a 1ml HITrap Chelating HP column was washed 
with 5ml distilled H2O, loaded with 0.5ml 0.1M NiSO4 solution and washed with 5ml 
distilled H2O again. The filtered sample was added to the affinity chromatography column 
at a speed of 1ml per minute and washed first with 10ml of binding buffer, then with 10ml 
wash buffer (6M urea, 20mM TRIS·HCl pH 8, 0.5M NaCl, 5mM imidazole, 1mM 2-
mercaptoethanol). The recombinant protein was eluted with 10ml 50mM TRIS·HCl (pH 
8)/10mM glutathione. The eluate was collected into 10 separate fractions of 1ml. The 
fractions containing the highest concentration of recombinant Rin1 protein were then 
dialyzed in PBS and concentrated to approximately 1mg/ml using CENTRIPLUS YM10 
centrifugal filter device (Millipore Corporation) with an exclusion molecular weight of 
30.000 Dalton. Rabbits were immunised and boosted at regular intervals. First bleeds were 
collected, crude serum extracted and tested in Western blot until satisfactory results were 
achieved. 
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4.2.4 Tail DNA preparation and PCR-based genotyping 
 
Mice were genotyped by PCR. Tail samples of mice, usually 4 weeks of age unless needed 
younger, were collected and heated three times for 15 minutes at 95°C in 100μl 50mM 
NaOH with vigorous vortexing between heating steps. After cooling, samples were 
neutralized with 10μl 1.5M Tris·HCl, pH 8.8 and remaining debris was pelleted. 1μl of the 
DNA solution was used as template in PCRs. PCRs were carried out with 50pmol of each 
specific primer, PCR buffer (500mM KCl, 15mM MgCl2, 100mM Tris·HCl, pH 8.8, 0.8% 
Nonidet), dNTPs (25mM each) and Taq polymerase (in house preparation) in a total 
reaction volume of 50 μl. 25 μl of the PCR reaction were separated on an agarose gel 
containing ethidium bromide and analyzed under UV light. 
 
Primers used for PCR analysis 
 
gene 
 
primer sequence 
rin1 exon75prC 5’-AAG TCC CTG CAT CGC TCT GTT CTC A-3’ 
 mRINintr7C 5’-ACA GGG CAC AAA GGC ACT ATT C-3’ 
 mRINneo 5’-TAT TGG CCG CTG CCC CAA AG-3’ 
   
ephA4 wt sense 5’-CAA TCC GCT GGA TCT AAG TGC CTG TTA GC-3’ 
 wt antisense 5’-ACC GTT CGA AAT CTA GCC CAG T-3’ 
 mut sense 5’-GAC TCT AGA GGA TCC ACT AGT GTC GA-3’ 
 mut antisense 5’-TTT TCT CCC TCT TTA AGC AAG GAT CAA GC-3’ 
   
GFP-M sense 5’-GCA CGA CTT CTT CAA GTC CGC CAT GCC-3’ 
 antisense 5’-GCG GAT CTT GAA GTT CAC CTT GAT GCC-3’ 
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4.2.5 Postsynaptic density preparation  
 
Post-synaptic densities were prepared as described in Cho et al, Neuron, 1992. In brief, 
forebrains of 6 wt C57/bl-6 adult male mice were homogenized in a dounce glass Teflon 
homogenizer in 12ml sol A and centrifuged at 3.000rpm for 10min at 4ºC. Pellets were re-
extracted with 5ml sol A, centrifuged at 1.000rpm for 10min at 4ºC, supernatants 
combined with the ones from the previous centrifugation and centrifuged at 10.000rpm for 
10min at 4ºC. Pellets were resuspended in 5ml sol B, overlaid on a 1.2M/1.0M/0.85M 
sucrose gradient and ultracentrifuged at 25.500rpm for 120min at 4ºC. A synaptic 
membrane fraction was extracted at the interface of 1.2M/1.0M sucrose layers and a 
control non-synaptic fraction was extracted between the top (0.32M) and the 0.85M 
sucrose layer. The synaptosome fraction was diluted to 9ml in sol B, 9ml of sol C was added 
followed by a 15min incubation on ice. The solution was divided into 6 samples and 
pelleted at 22.300rpm for 20min at 4ºC. One pellet was resuspended in 100μl sol D (PSD 
fraction1), the remaining five pellets in 5ml solB. 2ml of this solution were mixed with 2ml sol 
C, incubated on ice for 15min and centrifuged at 50.100rpm for 60min at 4ºC. The 
resulting pellet was resuspended in 100 μl sol D, 0.3% SDS (PSD fraction 2). The remaining 
3ml were mixed with 3ml sol E, incubated on ice for 15min, centrifuged at 50.100rpm for 
60min and the pellet resuspended in 100 μl sol D (PSD fraction 3). For a description of 
solutions used, please refer to the Materials section. 
 
 
4.2.6 Western blotting 
 
Samples obtained by biochemical procedures described elsewhere in the Methods section 
of this work as well as total cell lysates were denatured by boiling in SDS sample buffer 
and resolved by SDS PAGE according to standard procedures. Gels were transferred to 
nitrocellulose membranes (Protran, Schleicher&Schuell) by semi-dry blotting at 1mA/cm2 of 
membrane surface for 45 to 120 min. After completion, protein transfer was validated by 
PonceauS staining, membranes were blocked either in a 5% BSA solution in PBT or a 7.5% 
nonfat milk solution in PBT for 1h at RT and incubated o/n at 4ºC with primary antibodies 
diluted in blocking solution. Subsequently, membranes were washed in PBT for 1h at RT with 
several changes of PBT before incubation with secondary antibodies conjugated to HRP for 
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30-60min at RT in blocking solution. Finally, membranes were washed for 1h at RT in PBT 
before incubation with ECL solution (Amersham) for 1min and exposure to X-ray films 
(Kodak) to visualise signals. Membranes were stripped in 1x PBS, 2% SDS and β–
MercaptoEthanol (14μl per 100ml of PBS/SDS) for 30min at 65ºC and washed 3x for 
10min each in PBT at RT, if subsequent detection of another protein was necessary. After 
stripping, membranes were again blocked and treated as described above. 
 
 
4.2.7 Tissue lysis and Immunoprecipitation 
 
Dishes of cultured cells or neurons were placed on ice, washed 2x with PBS and cells were 
scraped in 0.5ml Cell Lysis Buffer (CLB) per 10cm dish. Lysates were left to rotate at 4ºC 
for 30min and non-soluble debris was pelleted at 13.200rpm for 5min at 4ºC. Brain 
samples were lysed in 3x volume to weight, e.g. 0.5g of tissue were lysed in 1.5ml CLB in a 
glass Teflon dounce homogenizer and subsequently treated as cell lysates. Lysates were 
frozen in liquid nitrogen and stored at -80ºC or used immediately. Protein concentration 
was estimated using the DC Protein Assay (Biorad). 
A specific antibody directed against the protein of interest was coupled to proteinA- (for 
rabbit polyclonal antibodies, Amersham) or proteinG-sepharose (for mouse monoclonal or 
goat polyclonal antibodies, Amersham) by rotating on a wheel at RT for 30min. Unbound 
antibody was removed from the beads by washing 2x with CLB. Lysates containing equal 
amounts of total protein were then incubated with the pre-coupled antibody-sepharose for 
2h on a rotating wheel at 4ºC and washed 3x with CLB to remove traces of unbound 
proteins. Equal amount of 2x sample buffer was added to the packed beads and samples 
heated to 95ºC for 5min to elute proteins. Samples were further analysed using Western 
blot analysis. 
 
 
4.2.8 GST pulldowns 
 
Equal amounts of  GST fusion proteins in solution were coupled to Glutathione sepharose for 
2 hours at 4ºC, washed three times with lysis buffer and incubated with lysate from cultured 
cells overexpressing potential interactors or total forebrain lysate for 2 hours at 4ºC. After 
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additional washes with lysis buffer, beads were boiled in equal volume of 2x loading 
buffer for 5min at 95ºC and loaded on a SDS gel. Standard western blotting procedures 
were applied to identify proteins of interest. 
 
 
4.2.9 Surface biotinylation 
 
Surface biotinylation of cells was carried out similar to the procedure described in  (Lin et 
al., 2000). In brief, stable HeLa-EphA4wt were split at a ratio of 1:10 from a confluent 
dish, transfected 24h later with either control plasmid (pEGFP-C/N1, Invitrogen) or 
Rin1FLmycHis, washed with PBSCaMg the following morning and supplied with starving 
medium (0.5% FBS). On the fourth day, starving medium was aspirated; cells were rinsed 
once with warm PBSCaMg and incubated with EZlink-NHS-SS-Biotin (Pierce, Rockford, Illinois) 
300μg/ml PBSCaMg for 2min at 37 ºC/5% CO2 to label all surface proteins. Subsequently, 
the biotin solution was aspirated, the cells rinsed once with warm PBSCaMg and incubated 
with starving medium supplemented with either Fc (control) or ephrinB3-Fc for different time 
points to trigger EphA4 internalisation. Endocytosis was halted by placing dishes on ice and 
rinsing them with cold PBSCaMg. Remaining biotin was stripped form the cell surface by 
incubation with reduced L-Glutathione (2.3g/50ml 150mM NaCl, pH8.75, Sigma) for 
30min at 4 ºC and glutathione was neutralized by incubation with Iodoacetamide 
(0.46g/50ml PBSCaMg, Sigma) for 10min at 4 ºC. Cells were lysed with CLB and lysates 
corresponding to equal amounts of total protein were incubated with Neutravidin sepharose 
(Pierce, Rockford, Illinois) on a rotating wheel at 4ºC for 2h. Beads were washed 2x with 
CLB and boiled in 2x sample buffer before Western blot analysis. 
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4.2.10 Tissue culture 
 
4.2.10.1 Cell culture 
 
Standard cell lines used in this work are Cos, HeLa, SK-N-BE2, PC12 and NIH-3T3. They 
were cultured on Falcon dishes according to ATCC’s (American Type Culture Collection) 
recommendations concerning splitting ratios and media requirements. 
 
 
4.2.10.2 Transfection by CaPO4 method 
 
Cells were split the day before transfection at a ratio dependent on the number of cells 
required. Transfection reactions for a 10cm dish were setup as follows. Usually, 10-15μg of 
plasmid-DNA were diluted in H2O to a total volume of 450μl. 50μl of 2.5M CaCl2 were 
added, followed by 500 μl 2x BBS (pH 6.96) and gentle vortexing. Reactions were left at 
RT for 15 minutes before carefully dripping them onto cells. Cells were washed with PBS 4-
12 hours after transfection and either supplied with fresh growth medium or starving 
medium depending on experimental design. Typically, cells were incubated 24-48 hours 
before analysis by Western blotting or immunofluorescence. 
 
 
4.2.10.3 Generation of stable cell lines 
 
HeLa cells were split 1:5 from a confluent dish onto 10cm dishes the day before 
transfection with 15μg pcDNA-EphA4wt or –EphA4KD by CaPO4 method. Cells were split 
into selection medium (growth medium, 400ng/ml Geneticin [Gibco]) upon reaching 
confluence on the transfection dish. Selection media was replaced daily to remove dead 
cells. Clones were picked after 2-3 weeks by removing the cellmass of individual islands 
mechanically with a sterile pipet tip. Clones were transferred to a 96well plate and 
eventually expanded to 10cm dishes by splitting when appropriate. One confluent 10cm 
dish for each clone was frozen in liquid nitrogen, another dish lysed and analysed by 
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Western Blotting with anti-EphA4 antibody. Positive clones were further analyzed by 
immunofluorescence. 
 
 
 
4.2.10.4 Primary neuron culture 
 
Glass coverslips were treated with 65% nitric acid at RT for 18-36h, washed extensively 
with H2O for 6-12h, rinsed several times in 100% Ethanol and dried. Coverslips were 
usually sterilized by baking at 175ºC o/n then coated with poly-lysine o/n at 37ºC, 5% 
CO2. The following day, coverslips were washed twice with sterile H2O and dried 
completely, then coated with laminin o/n at 37ºC, 5% CO2. Finally, they were rinsed twice 
with PBS and neurobasal/B27 media was added at least 3h prior to plating of neurons. 
 
Hippocampal, cortical or forebrain (hippocampus and cortex) neurons were taken from 
E18-E19 embryos. Mothers were killed by cervical dislocation and embryos were taken out 
of the uterus and kept in HBSS on ice. Heads were cut off, the skull opened and brains were 
placed in dissociation media. Cortices were separated and meninges removed before the 
cortex and hippocampus were dissected in fresh HBSS from unwanted brain tissue and 
placed at 37ºC in enzyme sol for 10-15min. Samples were washed three times at RT in 
inhibitor solution and then resuspended in neurobasal medium. Cells were dissociated with a 
rounded glass Pasteur pipette, counted and plated on coated glass coverslips in 
neurobasal/B27 medium. Cultures were incubated at 37ºC, 5% CO2 until analysed. 
 
 
4.2.10.5 Stimulation with ephrin-Fc fusion proteins 
 
As an in vitro system stimulation for Eph-receptors, soluble ephrin-Fc fusion proteins (R&D) 
were pre-clustered with goat-α-humanFc (R&D). Ephrin-Fc protein was used at a 
concentration of 1μg/ml of medium and incubated with α-humanFc antibody at a ratio of 
10:1 for 1h at RT, diluted in PBS. Pre-clustering of the Fc fusion proteins was applied to 
mimic the higher-order clusters of Eph-receptor and ephrin ligands believed to occur in vivo. 
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4.2.11 Immunofluorescence 
 
Cells or neurons grown on 12mm Ø glass coverslips (Marienfeld) were manipulated 
according to experimental design, placed on ice and rinsed once with cold PBSCaMg. Cells 
were fixed with 4% PFA/8% sucrose for 20min on ice, rinsed with PBSCaMg, incubated with 
50mM Ammoniumchloride for 10min at RT, rinsed again with PBSCaMg and permeabilised 
with PBSCaMg/0.1% TritonX-100 for 5min on ice. Samples were washed 3x 5min with cold 
PBSCaMg and blocked at RT for 30min with PBSCaMg/2% BSA/4% serum. Serum was chosen 
depending on the species where secondary antibodies were raised in, or a combination of 
different species sera was used if the combination of secondary antibodies demanded it. 
All the following steps of the protocol were carried out in a dark, humidified chamber to 
prevent drying of the coverslips. Cells were incubated with the specific primary antibodies 
diluted in blocking solution for 1h at RT, washed 3x with PBSCaMg and incubated for 30min 
at RT with secondary antibodies conjugated to fluophores, also diluted in blocking solution. 
For a list of fluophor-conjugated secondary antibodies, please refer to the Materials 
section. Coverslips were washed 5min at RT with PBSCaMg and incubated with a 1:3000 
dilution of Hoechst in PBS for 5min at RT. After a last washing step with PBSCaMg for 5min at 
RT, samples were rinsed briefly in ddH2O, carefully drained of excess liquid and mounted 
on glass slides with “Antifade Prolong” mounting medium (Molecular Probes). Samples were 
stored o/n in the dark to allow for complete hardening of mounting medium before analysis 
with a fluorescence microscope. 
 
4.2.11.1 Pre-/post-permeabilisation staining 
 
To monitor internalisation of surface proteins by immunofluorescence, the aforementioned 
protocol was altered as follows. After treatment of coverslips with Ammoniumchloride, 
samples were rinsed with PBSCaMg, blocked for 30min at RT and directly incubated with 
primary antibodies (pre-permeabilisation staining). Cells were washed and incubated with 
secondary antibodies as described before, rinsed with PBSCaMg and then permeabilized. 
Subsequently, samples were subjected to a second round of blocking, primary and 
secondary antibody incubation, this time the secondary antibody conjugated to a different 
colour fluophor (post-permeabilisation staining). This staining procedure allows for 
distinction between internalized receptor molecules and surface receptor molecules. 
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4.2.11.1.1  Quantification of internalisation 
 
The assay was performed as follows. In brief, HeLa cells stably expressing EphA4-receptor 
were transiently transfected with eGFP as a control or Rin1-FL and eGFP (ratio 1:5). were 
stimulated for 30min with pre-clustered ephrinB3Fc, then fixed and stained with a Cy5-
conjugated anti-Fc antibody (pre-permeabilisation staining) to reveal all surface clusters of 
EphA indirectly through detecting all clusters of ephrinB3Fc. Then cells were treated with 
0.1% Tx-100 and stained with a TR-conjugated anti-Fc antibody to identify all internal 
receptor-ligand complexes that had been protected from staining inside the cell in the 
previous step. Quantification of internalisation was done as follows. Pictures were acquired 
blind to the nature of the transfected plasmid and with equal exposure times for all pictures 
acquired in each channel. Ananlysis of pictures was performed with the MetaMorph 
software (version 6.3r7, Molecular Devices). Outlines of transfected cell shapes were 
marked in the GFP channel, outlines transferred to the surface staining channel and all 
surface clusters within the outline identified. A mask of marked surface clusters was then 
transferred to the total Fc stain channel and additional receptor-ligand clusters counted. 
Internalisation was expressed as a ratio for each cell analysed of internal divided by total 
number of clusters counted. The mean of all ratios in one group (either eGFP alone or Rin1 
and eGFP) was assessed and standard deviations and statistical revelance was calculated 
using the excel software (Microsoft® Office Excel 2003). 
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4.2.12 Histology 
 
4.2.12.1 Cardiac perfusion 
 
Mice were anaesthetised with chloralhydrate (400μl of a 5% solution in H2O, injected into 
the abdomen), skin and ribcage were cut open and the diaphragm was removed. A small 
incision was made into the right auriculum and a syringe connected to an electrical pump 
was inserted into the left ventricle to replace the animal’s blood by cold PBS. Blood 
removal was monitored by whitening of the liver, normally dark red. This was followed by 
approximately 25ml of 4% paraformaldehyde (PFA) solution for fixation. The level of 
fixation was assessed by checking tail stiffness. Brains were dissected out and postfixed 
overnight at 4ºC in 4% PFA.  
 
 
4.2.12.2 Cryosections  
 
Fixed brains were cryo-protected first by an overnight incubation in 15% sucrose solution in 
PBS at 4ºC, then a 30% step again overnight. Samples were carefully dried, then 
embedded in OCT on dry ice. Embedded brains were kept at -20ºC or the cryostat 
chamber until sectioning. Usually 50 μm sections were cut for a floating staining protocol. 
 
 
4.2.12.3 Vibratome sections 
 
Perfused and postfixed brains were embedded in a gelatine-albumin (gel/alb) mixture 
(0.5g gelatine in 100ml PBS, then dissolved 30g egg albumin in this solution). A layer of 
2ml gel/alb was poured into a small plastic mould and polymerisation started by 
vigorously stirring in 160μl 25% glutaraldehyde solution. The brain was placed on top and 
another 3ml gel/alb with 240 μl glutaraldehyde poured over it. The mould was left to set 
for 5minutes at RT before either storage in cold PBS or cutting with a vibratome. Generally, 
80 -100 μm coronal sections were cut for the in situ hybridisation protocol. 
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4.2.12.4 Antibody stainings on tissue sections 
 
Antibody stainings were generally performed on 40μm to 50μm floating cryostat sections. 
Immunofluorescence stainings were carried out as described for dissociated cells except all 
incubation times were prolonged to adjust for increased diffusion lengths of all compounds 
applied. Antibody stainings revealed by a HRP-conjugated secondary antibody were 
performed according to manufacturer’s instructions (vectastain), and pre-treated with a 
10% MetOH/3% H2O2 solution to quench endogenous peroxidase activity. 
 
 
4.2.12.5 In situ hybridisation 
 
All solutions used were prepared RNAse free. Sections were subjected to a MetOH 
dehydration series (25%, 50%, 75%, 2x100% MetOH, all steps 5min incubation at RT) and 
stored at least o/n at -20ºC. Samples were rehydrated in the reverse order and incubated 
3x 5min in PBT (PBS, 0.1% Tween20). Sections were digested with with 20μg/ml 
ProteinaseK in PBT for 13min at RT, rinsed 2x on ice with PBT and fixed for 40min on ice 
with freshly prepared 4% PFA, 0.2% glutaraldehyde before incubation with (pre-
)hybridisation solution (50ml contain 25ml de-ionised formamide, 12.5ml 20x SSC pH 4.5, 
100μl Tween20, 5ml 5% Chaps, 1g blocking reagent [Roche], 250 μl 10mg/ml tRNA, 
50 μl 50mg/ml heparin and 500 μl 0.5M EDTA pH 8.1) for 1h at 70 ºC. Probes were 
prepared as follows. For antisense probes, plasmids were digested at the 5’ end verifying 
complete digestion on an agarose gel before phenol-chloroform extracting the DNA. The 
transcription reaction was performed with 2 μl template DNA (100ng/μl), 2 μl 10x 
transcription buffer, 2 μl 0.1M DTT, 2 μl DIG, 1 μl RNasin and 1 μl of the respective RNA 
polymerase (T3, T7 or sp6) for 3h at 37ºC. 1 μl of the transcription reaction was checked 
on an agarose gel to verify efficiency. The RNA was precipitated by adding 100 μl TE 
buffer, 10 μl 4M LiCl and 300 μl EtOH before centrifuging at 13.000rpm for 20min at 
4ºC. Pellets were washed twice with 70% EtOH and dried briefly before resuspending in 
100μl TE buffer. 10-30 μl of probe was used per 1ml of hybridisation buffer. Sections 
were incubated with this hybridisation solution at 70ºC o/n. The following day samples 
were subjected to the following washing steps. 5min, then 3x 30min in solution I (50% 
Materials and Methods 
 107 
 
formamide, 5x SSC pH 4.5, 0.2% Tween20, 0.5% Chaps) at 70ºC, 5min, then 3x 30min in 
solution II (50% formamide, 2x SSC pH 4.5, 0.2% Tween20, 0.1% Chaps) at 66ºC, 5min, 
then 3x 30min in solution III (0.1% Chaps, 2x SSC pH4.5, 0.2% Tween20) at 66-68ºC, 2x 
5min in MABT (MAB pH 7.5, 0.2% Tween20) at RT and 2x 30min in MABT at 70ºC. 
Subsequently, sections were blocked for 90min at RT in blocking solution (MABT, 2% 
blocking reagent and 20% sheep serum) before incubation with the anti-DIG antibody 
(1:2000 in blocking solution) o/n at 4ºC. The following day, samples were washed 10x 
30min with TBT (TBS, 0.1% Tween20), rinsed in NTMT (for 200ml: 4ml 5M NaCl, 20ml 1M 
Tris·HCl pH 9.5, 10ml 1M MgCl2, 200μl Tween20) and equilibrated in NTMT for 20min at 
RT before developing the colour reaction in 1.4 μl NBT, 1.1 μl BCIP/ml NTMT. Development 
was stopped by rinsing in PBT. Samples were post-fixed in 4% PFA and mounted on glass 
slides with a 1:1 solution of 4% PFA and glycerol. 
 
 
4.2.13 Electrophysiology 
 
4.2.13.1 Slice preparation 
 
Adult EphA4-/- and EphA4wt/wt littermate controls were used for the investigation. The brains 
were removed rapidly and placed in ice-cold artificial cerebro-spinal fluid (ACSF) 
containing 125mM NaCl, 2.5mM KCl, 25mM NaHCO3, 2mM CaCl2, 1mM MgCl2, 25mM D-
Glucose, 1.25mM NaH2PO4 (pH 7.4) and bubbled with a 95% O2/5% CO2 mixture. 
Coronal slices of the amygdala (400μm) were prepared using a vibroslicer (FTB). After 
incubation in a holding chamber with ACSF (22-25°C) for at least 60min, the slices were 
placed in the recording chamber of the setup and superfused with ACSF at a flow rate of 
1.ml/min. 
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4.2.13.2 Electrophysiological recordings 
 
Stimuli were delivered via bipolar concentric tungsten electrodes insulated to the tip (50μm 
diameter), and positioned on the border between the lateral amygdala (LA) and the 
external capsule to evoke field potentials (FPs). All recordings were performed in the LA at 
room temperature (22-25°C). FPs were recorded using glass microelectrodes (1-2MΩ) 
filled with ACSF. The stimulus intensities were adjusted in a manner to produce a FP of 
~50% of the maximum amplitude. The voltage differences between the sharp negative 
onset and the negative peak (a), and between the negative peak and succeeding positive 
peak (b), were measured, and the amplitudes of the FPs were calculated as (a+b)/2. 
 
 
4.2.14 Microscopy 
 
Pictures of in situs in Figure 26, panels A, B, E and F were acquired with a LeicaMZFLIII 
stereomicroscope connected to a LeicaDC500 camera and the Leica image manager 1000 
software. All other antibody stainings and in situs were analysed with a Zeiss Axioplan 2 
imaging microscope. Images were acquired using either a Spot RT slider (colour images) or 
a Spot RT monochrome (immunofluorescence/ monochrome images) camera (Diagnostic 
Instruments, Inc.) and the MetaMorph software (version 6.3r7 and earlier versions, 
Molecular Devices). Confocal images were obtained with the LeicaTCS SP2 microscope and 
the Leica confocal software (version 2.61, Leica microsystems).  
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